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Abstract
Methamphetamine abuse is a problem of public health importance among men
and women in the United States. The two genders are affected even though the majority
treatment programs are tailored for male alcohol addicts. The gender differences are
prevalent in the acceptance of long-term substance abuse treatment programs. The study
focuses on gender differences in methamphetamine abuse and whether both male and
female addicts benefit from treatment. Respondent’s suitability, participant’s abuse
condition, treatment, and progress questionnaires and interviews are used to collect data
from 50 male and 50 female methamphetamine users at the Impact Residential Program
in Montreal, Canada. Together, the four quantitative questionnaires yield common factors
leading to methamphetamine abuse as weight loss and emotional stress for females, and
increased physical activity for males. Descriptive statistics of median and quartiles are
used to help describe outcomes of the treatment program. Stigma is identified as a
common barrier to seeking treatment for both genders. Furthermore, parenting and
childcare are not identified as barriers for females seeking treatment contrary to previous
research findings but pregnancy is a key motivator to seeking treatment. The median and
quartile descriptions reveal that both male and female methamphetamine abusers benefit
equally from treatment programs. The findings of this study add knowledge on genderspecific efforts against methamphetamine abuse. Public health officers may use identified
factors leading to methamphetamine use to foster preventive measures while officers
working in treatment programs may use identified motivators and barriers to treatment to
enhance program effectiveness.
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Chapter 1: Introduction to the Study
Background Information
National Institute on Drug Abuse (NIDA) (2008) acknowledges that abuse of
methamphetamine and amphetamines has been a problem in the US since the 1960s.
Clandestine production of methamphetamine escalated in 1990s after state regulations
withdrew injectable form of methamphetamine from the market and changed
methamphetamine to a schedule II drug that can only be obtained on prescription and
without refill (NIDA, 2008). In 2005, 1.3 million people in the United States reported use
of methamphetamine during the previous 12 months (National Survey on Drug Use and
Health (NSDUH, 2007). In 2004, 8% of treatment admissions from substance abuse were
for the abuse or dependence on stimulants. Remarkably, methamphetamine and other
amphetamines accounted for 99% of aforementioned admissions, which conforms that
they are popular stimulants (Substance Abuse and Mental Health Services Administration
(SAMHSA, 2007).
NSDUH (2014) reported that the 2013 national survey on drug use yielded 24.6
million Americans aged at least 12 years were current illicit drug users, defined as use
within the previous 1 month, in the year 2013. Importantly, this statistic represents an
estimated 9.4% of all persons aged at least 12 years, which confirms that drug use is a
plague in America. The most important illicit drugs are marijuana, cocaine, heroin,
inhalants, hallucinogens, and schedule II (prescription-type) drugs such as stimulants,
analgesics, sedatives, and tranquilizers. Although marijuana is the leading illicit drug
abused in America, methamphetamine is the leading prescription-type illicit drug used in

2
U.S.A (NSDUH, 2014). In fact, RAND (2009) posit that the number of amphetamine
users globally approximates that of heroin and cocaine users combined estimated at 28
million and 25 million users respectively.
In fact, NSDUH (2014) reported that current methamphetamine users for 2013
and 2012 remained steady at 0.2%, though exact number rose from 440,000 to 595,000
between 2012 and 2013. Additionally, a significant rise in methamphetamine
consumption between 2010 and 2013 was noted because the number of past month
methamphetamine users for 2010 was 0.1%. Even more worrying is the observation that
majority people start using methamphetamine at an average age of 21.6 years, which is
unequivocally a fundamental age in career development and academia. This statistic
shows that methamphetamine is heavily abused in the United States, which calls for a
corrective measure to reduce harm on the population.
In the process of controlling the effects of the abuse of methamphetamine,
professionals have noted several factors that influence the effectiveness, efficiency, and
treatment engagement of the treatment services provided. NIDA (2000) determined some
significant differences among men and women in the areas of drug abuse and treatment.
For instance, men are more likely than women to have access and opportunity to use
drugs despite the fact that both men and women are equally likely to use drugs for the
first time and progress into substance dependence (Kassada, Marcon, Pargliarini, &
Rossi, 2013). However, there is little comprehensive research that has been carried out
about gender differences among methamphetamine users, especially in their acceptance
of long-term substance abuse treatment programs (Winslow, 2007).
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The Office of Substance Abuse Services (2004) posits that rates of entry to
treatment, retention, and completion of substance abuse treatment are lower for women
than for men. This confirmed the findings by NIDA (2000) on the differences among
men and women in the areas of drug abuse and treatment. NIDA determined that women
who are engaged in substance abuse treatment are less likely to have graduated from high
school or to have stable employment compared to men. Besides, these women are more
likely to experience problems with their physical health, attempt to commit suicide, and
experience physical as well as sexual abuse (NIDA, 2000). However, probability that
women abusers will have previously sought treatment for substance abuse is higher
compared to men with similar problem (NIDA, 2000).
Research indicates that diverse treatment needs of women who use substances
tend to be overlooked and/or are inadequately understood (Weissman & O’Boyle, 2000).
In fact, the majority of studies on substance use and/or addiction focus on male
respondents (Schuckit, Irwin, & Brown, 1990). This observation was supported by
Kandall (2002) who noted that “most drug programs were still based on male treatment
models, many did not offer gender-specific services or accept pregnant addicts, and few
women held top administrative posts in the drug treatment field” (p.69). In fact, the
Mental Adjustment to Cancer scale, one of the Minnesota Multiphasic Personality
Inventory subscales used to assess alcoholism was originally tested on male alcoholics
(Kassada et al., 2013). Kassada and colleagues (2013) also noted that there are 14
primary issues specific to women with substance abuse disorder that need to be addressed
including low self-esteem, powerlessness, sexism, family of origin issues, unhealthy
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relationships, violence, incest, rape, sexuality, recreation, grief and loss, parenting, vision
for the future, and life plans.
Client characteristics differ between men and women in long-term substance
abuse treatment programs (Piper, 2008). The differences can be grouped into common
categories such as sociodemographic factors like age, educational level, employment
status, and marital status. For instance, majority women who use methamphetamine are
unemployed, single, less educated, and young, often below 40 years (Piper, 2008).
Notably, women often voluntarily reveal their addiction and seek treatment unlike
men who rarely seek help regarding their addiction (NIDA, 2008). For instance, NIDA
(2008) reported that women (19%) were more likely than men (16%) to report
methamphetamine abuse. In fact, majority men (39%) in substance abuse treatment
programs enter via criminal justice systems as compared to women (25%), which may be
attributed to the fact that fewer men will have voluntarily sought treatment prior to drugs
causing criminal behavior (NIDA, 2008). Unequivocally, these findings point toward
relationship between substance abuse and crime, which is a common reason as to why
men are incarcerated (NIDA, 2008).
Moreover, characteristics of men and women in treatment programs are different
in terms of employment (NIDA, 2008). According to NIDA (2008), there are little
chances that women who enter treatment are employed. In their report, NIDA reported
that 33% and 7% of men in treatment had full time and part time jobs respectively as
compared to only 17% and 8% of women who had full time jobs and part time jobs
respectively. Also, women who are addicted to methamphetamine also find challenges in
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seeking and remaining in treatment due to issues like child care and basic access among
others (NIDA, 2008). Unequivocally, aforementioned gender differences and the
different situations that women face mean that their treatment should be carried out
differently to incorporate the differences in feelings, perceptions and their stigma.
Methamphetamine addicted women also face numerous gender-specific
difficulties deriving from their economic, psychiatric, social, family, legal, and political
status (Amaro, Blake, Schwarz,& Flichbaugh, 2001). A study by Goldstein (2009)
revealed that over a 12-month period, the prevalence rate of anxiety and mood disorders
among women who abuse substances was 26.2% and 29.7% respectively, with disorders
of depression and phobia emerging as dominant. Additionally, addicted women
experience different physiological consequences from substance abuse, especially when it
comes to reproductive and sexual issues (Lex, 1994). These disparity issues still remain,
since women confront inequality within the substance abuse treatment environment, and
it is likely that women receive fewer benefits from a standard program. Notably, current
substance abuse treatment programs are mixed-gender standard programs that were
originally targeted at and designed for male substance abusers (Hser, Huang, Teruya, &
Anglin, 2004). Currently, only a few gender-specific programs that address special
problems faced by female substance abusers exist (Hser et al., 2004).
Statement of the Problem
The current makeup of substance abuse researchers and subjects mirror the gender
discrepancies of treatment. In substance abuse treatment outcome studies between 1984
and 1993, women subjects constituted only 7.8% of the research population (Vannicelli,
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1984). Furthermore, topics in most studies on substance abuse treatment have focused
heavily on biological, pharmacological, behavioral, or environmental aspects (Kassada et
al., 2013). These research trends disregard structural components such as gender, not to
mention class, race/ethnicity, and age (Korte, Merghati-Khoie, Rimaz, & Brady, 2014).
Overall, studies on gender differences in substance abuse treatment are scarce (Abadi et
al., 2012; Hser et al., 2004).
Additionally, most substance abuse treatment outcome studies have used a limited
number of outcome measures that often focus solely on substance use (Abadi et al., 2012;
Floyd, Monahan, Finney, & Morley, 1996). Such limited measures ignore other important
areas of outcomes for gender differences among substance abusers. The common
outcome measure of abstinence from drugs cannot estimate the whole range of changes in
male/female abusers` lives with treatment (Panchanadeswaran & Jayasundara, 2012).
Purpose of the Study
The purpose of this study was to establish the different effects that
methamphetamine abuse has on the different genders, and how either gender responds to
long-term treatment. This study provides basic guidelines towards the formulation of
policies aimed at curbing the menace of rising number of methamphetamine abusers, and
provides primary data that could be used for recommended future studies. To help
establish these trends, this study assessed the patterns of abuse by participants before
intervention, the different methods of treatment that are used, and the effectiveness of
different treatment methods between the two genders.
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With these circumstances in mind, this study sought to redress this analytical
imbalance. The researcher put emphasis on gender along structural components, and
developed gender-related factors as predictor variables. Gender-related factors refer to
the characteristics that create a difference between men and women as a result of bias in
political, economic, legal, social and psychiatric systems in the society despite campaigns
for gender freedom (Panchanadeswaran & Jayasundara, 2012). Importantly, these genderrelated variables were selected from previous studies on gender-specific or gender-related
conditions in substance abuse, and were measured at the individual level.
Research Questions and Hypotheses
The researcher developed the following research questions:
1. What are the different treatment needs for different genders in long-term
substance abuse treatment programs?
2. How can the needs of a gender-specific treatment be identified and implemented
to ensure full recovery of substance abusers in treatment programs?
The respective hypotheses for the above research questions are:
H01: There are different treatment needs for the different genders in long-term
substance abuse treatment programs.
H02: Different treatment programs should be implemented for men and women in
long-term substance abuse treatment programs.
Study Objectives
•

To use questionnaires and interviews to determine the reasons for
methamphetamine abuse among men and women.
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•

To use continuous monitoring questionnaires and interviews to determine the
effects of methamphetamine on women and men. This helped determine treatment
needs.

•

To use continuous monitoring questionnaires and interviews to track the progress
of treatment of methamphetamine. This helped determine the impact of treatment.
Nature of the Study
This study sought to answer questions regarding the identification and

implementation of different treatment needs that would eliminate the effects of substance
abuse among different genders in the long-term. I addressed the research questions
through collection and analysis of data from females and males who went through
residential or detoxification treatment and agreed to participate in mixed-gender longterm substance abuse treatment programs in Le Virage residential treatment Centre,
Montreal, Canada between 2009 and 2011. Using this data, I analyzed gender differences
in utilization and differences in outcomes as a function of gender.
I applied quantitative techniques in assessing different responses to treatment by
men and women. All measures of this research were based on participants’ self-reports
and, to some extent, existing medical and criminal records. One such quantitative
technique that has been used over the years is the California Treatment Outcome Project
(CalTOP) (Rawson et al., 2004). CalTOP was a study approach for treatment outcome
that covered participants from different regions (Rawson et al., 2004). Among the criteria
used to identify participants include their demography, geographical location, flow of
patient population, and commitment to CalTOP (Rawson et al., 2004).
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Finally, the study used generalized estimating equations model to examine the
long-term utilization measure of programs for substance abuse treatment and measure
treatment outcomes: methamphetamine use, family and social status, employment status,
and gender. However, it was impossible to evaluate gender differences in the costeffectiveness of long-term substance abuse treatment program as well as to assess the
impact of client characteristics on cost-effectiveness during the study period
Significance of the Study
The study was important because it made a comparison between the different
treatment needs of male and females and how these treatments should be implemented
for either gender effectively in long-term substance abuse treatment programs. Clinicians
benefited from the study too since they got the chance to learn about motivational and
relapse avoidance issues that are influenced by gender and social adjustment, as well as
other factors that influence the response of patients to treatment.
Being able to determine the treatment needs of females and males during
treatment allowed providers to better meet client needs and the most appropriate setting
for provide substance abuse treatment. Knight, Logan and Simpson (2001) stated that
“the more engaged clients are in treatment, the more likely they are to stay in the program
to reap further benefits” (p.535). In addition, alternative treatment models are capable of
addressing universal issues like sexual abuse and domestic violence that affect women
(Nelson-Zlupko, Dore, Kauffman, & Kaltenbach, 1996; Panchanadeswaran &
Jayasundara, 2012). A demonstration that the presence of a woman’s child during her
treatment improves the chances that she completes the treatment successfully would call
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for the creation of programs with funding aimed at meeting the childcare needs of the
women. Interventions could be directed towards the mother’s substance abuse treatment
as well as offering her parenting skills during the recovery process. This is especially
important because Hodgins, El-Guebaly and Addington (1997) discussed the reasons
women seek substance abuse treatment less often than men is because women bear the
greater burden of caring for the children.
Determining the gender differences in needs during treatment in different types of
treatment settings, whether women-only or mixed, may assist in care from mental health
professionals. Green, Polen, Dickinson, Lynch and Bennett (2002) stated that
determining the uniqueness of gender as it relates to treatment would potentially improve
total treatment outcomes. If treatment setting can reduce anxiety levels, greater emphasis
can be placed on empowering women to address factors like depressive symptoms,
physical, and emotional problems that contribute to their substance abuse (Abadi et al.,
2012). As Weissman and O’Boyle (2000) posited that “services provided to women
addicts must be set in a context that empowers them, improves coping skills, and helps
them to develop functional support” (p.2), professionals in the field will be better
equipped to advocate for women and the type of treatment setting that will best serve
their recovery process and rate. Nelson-Zlupko et al. (1996) report that clinicians should
become advocates for women by becoming informed of the various needs of women.
Research Assumptions
This research applied a mixed method research design entailing the use of
questionnaire surveys and interviews with both the patients taken in for
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methamphetamine abuse and their clinicians. Therefore, I assumed that all clients that
participated in the study would respond with utmost honesty to the self-report inventories
of their needs and how best these needs should be implemented in a long-term substance
abuse treatment programs. Notably, participants were expected to have the ability to read
the questionnaires and understand the questions. Respondents who had no ability of
reading or understanding the contents of the questionnaires were guided by the researcher
to ensure that they responded as required. Also, I assumed that all the clinicians
interpreting the inventories were well versed with rehabilitation services and would
accurately interpret each gender`s needs and would be able to provide the best treatment
suggestions for implementation in a long-term substance abuse treatment program.
Study Limitations
The limitations of the study included the fact that the sample collected could not
be generalized to other populations as it is from a single long-term substance abuse
treatment program in an urban setting. Another limitation was the fact that the
respondents may have withheld some information with the view of impressing the
researcher, yet blinding was unfeasible. The fact that the study only involved 100
participants made it a limitation to conclude that all the abusers of the drug in the world
have similar experiences.
Definition of Terms
Gender: According to the American Psychological Association (2011), gender refers to
attitudes, feelings and behaviors that a given culture associates with a person’s
biological sex.
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Long-term Substance Abuse Treatment: A long-term program designed to cure or to
reduce the severity of a substance use disorder (Piper, 2008).
Methamphetamine: A powerful, highly addictive, stimulant that affects the central
nervous system (NIDA, 2013).
Methamphetamine Addiction: Will include DSM-IV definition of substance dependence,
which connotes physiological or psychological dependence on methamphetamine
(Abadi et al., 2012).
Retention: The act of remaining in treatment until the whole process is complete (Green
et al., 2002).
Substance Use Disorder: Problematic use of a drug of abuse including but not limited to
alcohol, cocaine, marijuana, heroin, and methamphetamine that is known to cause
difficulties in social functioning and medical illness (American Psychiatric
Association, 2000).
Treatment Completer: A client who was found to have met all, or a sufficient amount, of
the treatment goals to warrant what was considered to be successful completion as
determined by his/her counselor (VandenBos, 2007).
Treatment Noncompleter: “A client who terminates treatment before it is completed”
(VandenBos, 2007, p. 302), For this study, a client who left the program
prematurely, either on personal decision or as a result of mandatory dismissal that
may result from violation of treatment rules was referred to as treatment
Noncompleter.
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Summary and Transition
Methamphetamine abuse and dependence has been a long-standing problem in the
United States (Whitebread, 1995). Several legislations have been implemented to control
the production, distribution, and use of these illicit drugs (Clinton, 1993; Drug
Enforcement Administration, 2012; McWilliams, 1990; Whitebread, 1995). Several
treatment modalities have been developed to help treat current users (Hunt, Kuck, &
Truitt, 2006). Despite these efforts that problem remains steady (SAMHSA, 2008).
Similarly, legislative, research, and treatment efforts have been made to curb the abuse
and dependence on methamphetamine (SAMHSA, 2008). However, the number of
individuals, males and females reporting abuse of and dependence on methamphetamine
continue to rise (SAMHSA, 2004).
Research efforts need to be continued in order to improve the efficacy and
efficiency of treatment modalities for persons who report methamphetamine abuse and
dependence. Little research exists regarding the gender differences in their acceptance of
long-term substance abuse treatment programs in treating methamphetamine abuse and
dependence (Hser et al., 2004). Current substance abuse research indicates that positive
treatment outcomes are associated with high levels of needs-matching and treatment
engagement (Fiorentin, Nakashima, & Anglin, 1999; Hser, Maglione, Polinsky, &
Anglin, 1999). Therefore, it is important to identify the needs of each gender with
methamphetamine abuse or dependence in order to increase the effectiveness of longterm treatment.
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Chapter 2: Literature Review
Synopsis
There have been many studies regarding effects of addiction to drugs among
women and men. A number of the studies have revealed that treatment is able to make
the addicted patients avoid relapse, stop the use of drugs, and completely overcome the
effects of addiction. Some of the key principles that have emerged regarding the basis of
an effective treatment program include the following:
• The treatment needs being readily available (2008; Kassada et al., 2013).).
• No single treatment considered appropriate for everyone Drug Rehabs,
2008; Kassada et al., 2013).
• Addiction being a complex but treatable disorder affecting both the
behavior and brain function (Kassada et al., 2013).
• Remaining in treatment for long and adequate period considered critical in
the success of the treatment program (Drug Rehabs, 2008; Kassada et al.,
2013).
Specifically, comprehensive cognitive-behavioral interventions, contingency
management interventions, residential rehabilitation, medications, mutual support or selfhelp groups, and stimulant treatment programs are examples of programs or treatment
options considered effective in treating methamphetamine addiction (Korte et al., 2014).
As earlier outlined, the circumstances surrounding drug abuse or use vary greatly based
on gender differences (Kassada et al., 2013).
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This chapter is a literature review on the effects of addiction to methamphetamine
on different genders, and the reactions of the addicts of these genders to long-term
treatment. These are achieved by reviewing literature on reasons for abuse and addiction
by different genders, treatment response based on gender, factors affecting the different
genders in responding to the long-term treatment programs, diverse treatment needs
meant for the different genders in long-term substance abuse treatment programs, relapse
during and after treatment, treatment outcomes and a conclusion for the chapter.
Effects of Methamphetamine Use
Methamphetamine is an odorless, white, bitter, crystalline drug that easily
dissolves in water or alcohol (Piper, 2008). Thus, the drug can be consumed through
intravenous injection, oral consumption, smoking, or snorting the powder through the
nose (NIDA, 2010; Piper, 2008). Immediately after intravenous injection or smoking, the
methamphetamine user experiences a strong sensation referred to as a “flash” or “rush”
(NIDA, 2010) The flash is then followed by a soaring that can last for as long as 6 to 8
hours (Piper, 2008). Nasal or oral use produces a similar lasting high, but lacks the
powerful or strong rush (NIDA, 2010).
According to NIDA (2013), some pleasurable short-term and long-term effects
drive methamphetamine use. However, methamphetamine has a plethora of short-term
and long-term effects, majority of which are harmful to the body. Short-term effects
include euphoria, increased attention and wakefulness, increased physical performance,
decreased fatigue, and decreased appetite (NIDA, 2013). Notably, these are the very
reasons majority people consume methamphetamine. Additional short-term effects of
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methamphetamine include rapid heart rate (tachycardia), increased respiration
(tachypnea) and hyperthermia (NIDA, 2013). Importantly, tachycardia and tachypnea are
methamphetamine-induced physiologic changes that help sustain its other effects related
to increased physical performance with little fatigue (NIDA, 2013).
Conversely, methamphetamine use produces various long-term effects, some of
which are desirable to the user, but majority are the very reason methamphetamine abuse
requires treatment. Specifically, methamphetamine causes mood disturbances, aggressive
behavior, psychosis including paranoia, repetitive motor activity, hallucinations, memory
loss, impaired cognition, and deficits in motor skills (Nordahl, Salo, & Leamon, 2003;
Otero, Boles, & Young, 2006). Additionally, methamphetamine use may cause changes
in brain anatomy and function, dental problems, and weight loss (Nordahl, Salo, &
Leamon, 2003). Unfortunately, methamphetamine use also causes addiction, which
complicates the situation because the user will henceforth be incapable of quitting despite
experiencing all the undesirable effects. This explains why tackling the issue of
methamphetamine abuse requires change of tactics from sentencing to treatment (NIDA,
2013).
Unequivocally, weight loss is the only long-term effect that may be termed
desirable albeit at high risk of developing other long-term effects. Additionally,
combination of memory loss, reduced motor skills, and aggression affect important
domains of life, especially related to work, social interactions, and academia, which
together inflate the economic burden of methamphetamine use (Homer et al., 2008;
NIDA, 2013). In fact, RAND (2009) estimates that the economic burden of
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methamphetamine use for 2005 for the United States was $23.4 billion, which was
inclusive of treatment cost, lost productivity, child endangerment, production harms,
criminal justice costs, and premature death.
Research indicates that the proportion of female methamphetamine users is
significant and almost similar to that of men (Piper, 2008). Importantly,
methamphetamine may also adversely affect pregnancy outcomes and the developing
fetus (NIDA, 2013). According to NIDA (2013), placental abruption (placenta separating
from uterus before term) and premature labor have been documented. Besides, prenatal
exposure to methamphetamine is associated with small for gestation, brain and heart
abnormalities, decreased arousal, increased stress, and lethargy (NIDA, 2013). Hence,
failure to control methamphetamine abuse in women increases risk for health
implications to children, which in turn increases national health expenditure, perhaps far
beyond cost of rehabilitating the female addicts in the first place.
Methamphetamine use also increase risk for Human Immunodeficiency Virus
(HIV) infection via route of administration and psychological effects (Weissman &
O’Boyle, 2000). Precisely, intravenous route of methamphetamine use is popular among
users because of high intensity of euphoria it produces (NIDA, 2013). Unfortunately,
users tend to share needles, which increase risk for HIV, hepatitis B and hepatitis C
transmission (Weissman & O’Boyle, 2000). Also, methamphetamine increases sexual
functioning, which increases risky sexual behavior including unprotected sex perhaps
with multiple partners (NIDA, 2013).
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Characteristics of People Who Use Methamphetamine
Hunt, Kuck, and Truitt (2006) reported that methamphetamine users in the United
States are predominantly Whites in their 20s-30s, with majority falling within the under
34-years group. According to the authors, methamphetamine-use menace affects both
men and women almost equally, estimated at 45% of women and 55% of men, but Piper
(2008) reported 47% women and 53% men. Piper further analyzed characteristics of
women who use methamphetamine users and reported that an estimated 15% are single
parents, which is four times the proportion of single parent male methamphetamine users.
Although Hunt, Kuck, and Truitee (2006) argued that meth users were historically
college students and white-collar job employees, Piper (2008) reported that up to 40% of
women who use methamphetamine are unemployed vis-à-vis 10% of men. Additionally,
Piper observed that female methamphetamine users who seek treatment have an
averagely higher frequency of use compared to men. Moreover, women in treatment
programs for methamphetamine have a significant history of physical abuse, sexual
abuse, and psychological trauma (Piper, 2008). In fact, the women have a four-fold risk
for sexual abuse within 1 month prior to entering treatment (Piper, 2008). Therefore, it is
unequivocal that methamphetamine users form a heterogeneous population when
focusing on both intragender and intergender characteristics.
Gender Differences in Reasons for Abuse and Addiction
Initial consumption of drugs plays a significant role in addiction and their abuse,
especially due to users’ experience (Korte et al., 2014). Effects such as the reduction of
fatigue, wakefulness, increased attention, and increased body activity influence the
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consistency that the users consume the drugs (Piper, 2008). Some individuals start using
methamphetamine to lessen fatigue and maintain a certain level of productivity especially
for repetitive, tedious, or physically demanding tasks or when working for long hours
(Piper, 2008). This explains why meth was originally popular among soldiers serving
active combat (Piper, 2008). Some users also believe the drug improves sexual desire and
activity, and others abuse the drug with the hopes of losing body weight (National
Clearing House for Alcohol and Drug Information (NCHADI), 2011). However, when
considering gender differences, a variety of reasons arise based on gender as to why
either men or women use methamphetamine.
Researchers have pointed out different reasons that make different gender groups
abuse drugs. According to a research conducted by Brecht, Anglin, Mayrhauser, and
O’Brien (2004), the most common causes of drug abuse among men include having
better sex, working for more hours, or to have a good or enjoyable time. These are
contrary to the reasons that these researchers cited for women abusing drugs. Women in
most cases abuse drugs to escape the poignant or emotional distress that is caused by the
occurrence of victimization or sexual abuse (Brecht et al., 2004). Additionally, women
use drugs as a result of influence from their partners (Brecht et al., 2004). In fact, Brecht
et al. demonstrated that women were increasingly likely to be initiated to
methamphetamine use and continually gain access to it via their male partners than were
the men. Therefore, patterns of use of substance among married women mirror that of
their spouse.
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Notably, gender differences postulated in the study by Brecht et al. (2004) are
consistent with findings by Korte et al., (2014), who argued that in general, men abuse
drugs in order to get high while women take drugs to relieve stress. Korte and colleagues
concluded that men in most cases use drugs as an adventure while women use them for
self-medication.
Additionally, Abadi et al. (2012) postulated that gender differences in drug
addiction rather than use also exist. According to the authors, drug-dependent men are
more likely to use drugs for socialization and externalization of childhood problems
while the drug-dependent women are likely to use substance in coping with a negative
mood and when in need of help for an emotional problem at a tender age as opposed to
men. Abadi and colleagues also reported that a high likelihood exists that drug-dependent
women have attempted suicide and have an internalized problem that affected them in
their childhood. Hence, treatment efforts may be futile if gender differences pertaining to
drug addiction are not considered
Specific to methamphetamine use, Piper (2006) reported that 37% and 8% of
Californian women and men respectively use methamphetamine to lose weight.
Additionally, the Piper reported that proportion of men and women who use meth to
relieve depression is equal. Therefore, it is naïve to continue running treatment programs
that are primarily founded on behaviors and/or characteristics of male users only.
Treatment Response Based on Gender
In relation to long-term treatment programs, a variety of studies have indicated
that differences exist pertaining to the response of drug abusers to treatment. Drug
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abusers have been found to respond differently to long-term treatment programs based on
gender (Hser, Evans & Huang, 2005). Importantly, these differences among individual
men and women found in the drug/substance abuse and treatment areas further inform the
purpose of the current study. Focusing on these differences, and owing to the biological
make-up of women, in most cases women tend to visit their healthcare providers more
often than their male counterparts. This implies that a female substance abuser is more
likely to be identified by a healthcare professional owing to emotional and behavioral
effects of a drug, which may increase propensity to enrolment in treatment program.
According to Hernandez-Avila (2004), women undergoing treatment will have
repeated psychiatric problems as opposed to men. The response that women drug abusers
exhibit is also influenced largely by their biological makeup (Hser, Evans & Huang,
2005). The biology of a woman enables her to experience a similar level of addiction and
intoxication while using less amount of substance than the one used by a man.
Unequivocally, methamphetamine abuse can cause health problems that can be detected
from physical appearance of the patient. Within this particular population, Brecht et al.
(2004) argued that females are actually more likely to experience a skin problem and
report it as opposed to the males who are likely to experience and report the effects that
influence their performance at work. Rowan-Szal et al. (2009) conducted another study
that focused on the female gender treatment. The study, which examined the
characteristics of the female offenders having a substance abuse history of a major
impairment related to methamphetamine use, was aimed at comparing the traditional
outpatient (OTP) treatments and a therapeutic community program called clean lifestyle
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(CLIFF-TC) (Yun et al., 2012).The study paid close attention to female
methamphetamine-use offenders who were treated either in a modified CLIFF-TC
program developed for the nonviolent offenders with a major impairment from the use of
methamphetamine, or standard OTP treatment. All the participants in the study were
assessed on social and psychological functioning, motivation, and treatment engagement
during and after treatment (Rowan-Szal et al., 2009). Both OTP and CLIFF-TC were
shown to improve psychological functioning with major changes being reported on
measures of depression, self-esteem, decision-making, anxiety, risk taking, hostility, and
errors of criminal thinking (Rowan-Szal et al., 2009). Both groups of participants rated
treatment engagement measures of satisfaction, participation, and counselor rapport to be
extremely high (Rowan-Szal et al., 2009). The results obtained in this study had a
positive implication in the improvement and management of treatment of female
methamphetamine-use offenders given that psychological improvement during the
treatment had been associated with better release outcome (Rowan-Szal et al., 2009).
Hartman, Listwan and Shaffer (2007) examined women and men who used
methamphetamine in a community based drug court to find out if gender influences
treatment outcomes. According to the study, treatment of female drug users was a salient
issue due to concerns of recidivism and relapse (Hartman, Listwan & Shaffer, 2007). The
study examined the impacts of the drug court based on gender of high-risk/high need
users of methamphetamine. Multivariate analysis indicated that men had a higher failure
probability over a period of 18-months (Hartman, Listwan & Shaffer, 2007). The results
further suggested that a comprehensive drug court could be an effective strategy for the
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women methamphetamine users having a variety or an assortment of needs (Hartman,
Listwan & Shaffer, 2007).
Factors Affecting Different Genders in Responding to Long-Term Treatment
Programs
It is very vital to comprehend issues that are related to gender differences among
methamphetamine users particularly, in their acceptance of long-term programs of
treatment regarding drug abuse. The understanding of these issues is dependent on the
factors that influence or affect the entry to treatment, retention, and completion of
substance abuse treatment facilities. A number of factors can influence the level of
treatment engagement, effectiveness, and efficiency of substance abuse treatment
services. Some of the factors that influence different genders and their response to longterm treatment programs are family and society factors, and social stigma (Westermeyer
& Boedicker, 2000). The society and family in most cases usually puts more pressure on
the drug-abusing woman than man to seek for treatment. This implies that women in
most cases will be having a higher propensity to enter treatment sooner after substance
abuse onset than men. This, coupled with the biological fact that women require a lesser
amount of substance to feel a similar intoxication level as men, contributes largely to the
response of women seeking treatment earlier than men (Harnandez-Avila, Rounsaville, &
Kranzer, 2004). The probability of a woman becoming pregnant or having a baby also
forms a huge motivator for women entering treatment early. The American society does
not accept women using drugs when pregnant and therefore, this societal pressure usually
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becomes the momentum for several women to abandon using drugs and register
themselves into a rehabilitation program for the wellbeing of the unborn child.
Women who use methamphetamine face unique barriers to treatment and
recovery including the fact that majority women are the primary caretakers of their
children. Unequivocally, pregnant, breastfeeding, and female users with dependent
children may hesitate entering residential rehabilitation programs if childcare services are
absent. Similarly, keeping appointments including punctuality is an issue for the same
cohort of female patients who enter outpatient treatment services. Besides, women who
use methamphetamine enter treatment with additional need for psychological treatment
given that majority will have had physical abuse, sexual abuse, and psychological trauma
(Piper, 2006). Very few facilities in U.S are equipped to handle diverse treatment needs
of women. According to Piper (2008), only 32% had programs tailored for women
substance users, with only 14% suiting pregnant and breastfeeding women. In fact, the
author reported that an estimated two-thirds of women who use methamphetamine who
seek treatment have minor children yet less than 8% of all U.S programs offer childcare
services and less than 5% offer residential child services.
The steady rise in the use of methamphetamine necessitates understanding of the
factors that influences decision of an individual to enter a methamphetamine treatment
program in order to address use of methamphetamine effectively. Apart from the family
and society pressure that seems to affect women more than men, and the biological
reasons encompassing pregnancy and women’s biological make-up, a factor that affects
both genders in more of an equal measure is social stigma. Based on a number of studies,
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social stigma forms one factor that has been indicated to impact the long-term treatment
benefits among the drug users. A study conducted by Semple, Grant, and Patterson
(2005) examined the relationship found between drug-use stigma and the use of drug
treatment services in a sample of 292 heterosexual users of methamphetamine. The
participants, who had been in treatment for use of methamphetamine, were compared
with their counterparts who had never been in any treatment. A total of three stigma
dimensions were examined. According to univariate analysis, participants who had never
been in any treatment for using methamphetamine reported significantly more rejection
expectation and endorsed more stigma-coping mechanisms or strategies contrary to the
participants who had been in a methamphetamine use treatment. The findings of the study
indicated that stigma was a potential barrier to drug use treatment. Specifically,
implications of the study findings were two-fold: Drug use stigma may be a potential
barrier to seeking treatment among methamphetamine users, and the stigma (drug-use
stigma) may play a significant role in the non-completion of the treatment programs
(Semple, Grant, & Patterson, 2005).
Diverse Treatment Needs Meant for the Different Genders in Long-Term
Substance/ Drug Abuse Treatment Programs
Several studies on the treatment needs of women have belabored need for genderspecific programs if women who use drugs are to be supported (Kassada et al., 2013;
Weissner & O’Boyle, 2000). Various studies are concerned with the etiology and
epidemiology of drug abuse among women as well as development of strategies that have
the ability of addressing the gender specific needs of women (Yun et al., 2012).
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Treatments needs vary from the type of service needed to the program style, and other yet
to be addressed issues. Comprehensive, multisystem models of treatment have been
selected as the standard of care for female substance abusers (King, Aliata, Cloak, &
Chang, 2010). For the community-based programs, the most notable needs for women are
perceived to include training in parenting and childcare, help with transportation,
vocational or educational training, medical care, and help with housing. Piper (2008) and
Wang et al. (2012) posit that women’s treatment programs should have different styles of
delivery that have the ability of improving the women’s empowerment levels, building of
skills, support, and identification of strengths.
Treatment models that have been developed particularly for the treatment needs
of women comprise of the models that focus on women’s relational orientation and
empowerment, and feminist models that seek to comprehend the behavior of the
substance-using or drug abusing women within the context of dominant culture. The
models for the specialized populations of women have also been identified, including
programs that are meant for the female offenders including pregnant women who use
substances (Pelissier & Jones, 2005). Some individuals believe that women can actually
do better in an all-female setting due to the fact that the atmosphere created in such a
setting is more supportive and nurturing and may provide a safer surrounding for women
to talk about personal experiences and feelings related to sexual and physical abuse
(Pelissier & Jones, 2005). Female-only programs have been recognized to give an
increased number of ancillary services required by women, which are able to facilitate the
enrolment and retention in a treatment program (Luo, et al., 2015).
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Besides women-only participants, staff members who are all female and can serve
as role models are perceived as providing a positive influence on the environment of
treatment. Pelissier and Jones (2005) further argued that drug treatment programs with
female participants should consider the comprehensive range of problems in women a
vital issue. Besides, treatment programs dealing with female substance abusers have also
been perceived as requiring special attention to relationship issues including those that
women have with their partners as well as with other family members. Various studies on
program needs for women who abuse drugs claim that the programs that are mostly used
in drug abuse treatment have been subjective towards the male gender needs (Wang et al.,
2012). Because of this, there has been an increasing body of conceptual research on
developing or designing programs that actually advocate for and include strategies to
handle needs of women who abuse drugs such as methamphetamine (Luo, et al., 2015).
The single-gender treatment programs need to discuss and explore different
substances that are abused and the reasons as to why they are abused (Jenner & Lee,
2008). For the female gender, prescription drugs are usually the substance that is abused
(Heseltine, 2006). Common labeled indications for some prescription drugs that end up
being abused are anxiety disorders, mood disorders, and pain. Conversely, some women
tend to consume these drugs with the aim of addressing other issues such as weight loss,
only to get addicted after repeated use (Wang et al., 2012). In fact, Jenner and Lee (2008)
argued that attitude of the society on weight of women is important factor that pushes
women to abuse some prescription drugs as a method of shedding off a few pounds.
Besides, some women illegally take some prescription drugs for stimulant effects
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(Heseltine, 2006). The idea of some women having a low self-regard is a key motivation
for women to try drugs. A treatment program that is gender sensitive would provide
methods of boosting the confidence and self-esteem of women. This is because the
single-gender programs always foster an empowerment sense in a supportive and safe
environment, which in turn goes a long way in building confidence in women
(Panchanadeswaran & Jayasundara, 2012). Importantly, researchers have noted that
allowing patients to manipulate the message of the program in order to fit their individual
needs ensures that confidence is fostered.
Unequivocally, differences found between women and men in substance or drug
abuse programs are vital and thus need to be considered in-depth (Hser, Teruya, Huang,
& Anglin 2004). A number of aspects of drug abuser lifestyle are distinct between
genders. Importantly, these differences may not be addressed completely in programs
involving mixed genders, yet single-gender programs present therapy needed for women
to attain a lifelong and full recovery. In a gender-sensitive group, single-gender
discussion will provide individual members with a comprehensive understanding of what
exactly the other members are actually tackling (Abadi et al., 2012). Moreover, it will
give a safe environment to address the social and family issues including topics that are
specific to the biological make-up of women (Bride, 2001; NeSmith et al, 2000). Hence,
gender-specific treatments currently need to be designed and studied to put in what is
already known and to increase the understanding of treatment program developers on
strategies of ensuring long-term sobriety.
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Relapse During and After Treatment
Relapse is an important challenge in management of substance-use disorders that
can be used to measure success rates. A recent study conducted by Jenner and Lee (2008)
in Australia examined the long-term use of methamphetamine in three categories or
groups: Methamphetamine-users treated in in-patient (residential) rehabilitation center,
methamphetamine users treated via a short-term detoxification program and
methamphetamine users who underwent no form of treatment. The authors reported that
most of the methamphetamine addicts actually relapse within a period of three years upon
seeking treatment (Jenner & Lee, 2008). The study also indicated that relapse rate of
individuals who go for rehabilitation is about 88%. Individuals who go for rehabilitation
have quicker success, estimated to be about twice that of those individuals who undergo
normal detoxification program (Jenner & Lee, 2008).
The residential rehabilitation program, which normally integrates recreational
activities and counseling as part of in-patient treatment, reported an elevated short-term
rate of success with 48% reported to have overcome addiction in a period of three
months. The individuals who went through the short-term detoxification, which takes
place for a shorter duration at the facility, had high chances of relapse almost similar to
the controls, who received no treatment. Specifically, only about 15% of these people
were able to gain full recovery from the treatment. However, even the individuals who
had gone to the rehabilitation center had a very low success rate considering the extended
duration of treatment: Only 12% reported no relapse after a period of three years as
opposed to the 5% who never went to the rehabilitation center (Jenner & Lee, 2008).
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Treatment Outcomes
Regarding the subject of treatment outcomes among methamphetamine abusers,
which is associated with the acceptance of treatment programs by abusers, literature is
based on short and small sample-size clinical trials that test specific medications.
However, a few longitudinal studies on treatment outcomes regarding methamphetamine
abusing patients have provided promising results. Hser, Evans, and Huang (2005)
conducted a longitudinal study to examine treatment outcomes among methamphetamine
abusing patients of both genders using a sample of 1,073 participants comprising of 567
women and 506 men drawn from 32 community-based residential and outpatient
programs in 13 counties in California. The study aimed at addressing the drug use
patterns among meth-abusing patients prior to entering a treatment program, changes in
patient behaviors after treatment, and gender differences among the drug abusers in
various phases. Data was collected at the stages of entry and after three months and nine
months from entry into treatment. With a single exception, enhancements from baseline
record were observed in all areas measured using the Addiction Severity Index (ASI) for
both men and women in either modality. As opposed to the men, the women showed
greater advancement in medical problems and family relationships, and the same
advancement in all the other areas despite the fact that most of them were unemployed,
had responsibilities of childcare, were staying with someone who also used drugs or
alcohol, had been abused sexually or physically, and reported increased psychiatric
symptoms. The study results confirmed that methamphetamine abusers formed a category
with multiple problems in key life areas. The most noticeable problems were legal
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problems, employment problems, psychological distress, and parenting (Hser, Evans, and
Huang, 2005).
Services that were provided during treatment were focused largely on drug and
alcohol problems and to a lesser extent on the domain of mental health. Whereas it is
understandable that drug and alcohol services need to form the basis of treatment
programs, the severity and complexity of the related family, legal, and employment
problems of drug abusers are considerable impediments to unrelenting reductions in drug
use. Improved strategies of intervention need to target both substance abuse and the other
related needs that are required for a successful rehabilitation.
According to the findings of the study by Hser, Evans, and Huang (2005), women
participants, most of whom had children or were of child bearing age, showed more
severe problems than the men. This accounts for the reasons as to why the females seek
treatment earlier than the males. Most of the women in the sample were unemployed,
depended on the assistance by the public, and suffered from extreme or severe psychiatric
conditions or problems. Therefore, the development and delivery of adequate services to
address or handle the needs and problems of women undoubtedly will improve the
outcomes of the treatment programs and thus affect the acceptance of the programs by the
meth abusers.
Additionally, the study by Hser, Evans, and Huang (2005) demonstrated that
women seemed to have increased problem severity, but at the same time appeared to
show superior improvement in several areas. Women in the sample who were treated in
the outpatient programs reported to have received greater services intensity than men.
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Therefore, greater improvement of women may be attributed partially to the services
provided. Conversely, these individual women may be more aggravated than men for
recuperation from using methamphetamine owing to their key responsibilities in their
families, or due to the fact that they are actually more responsive to the treatment
programs and thus have better outcomes overall.
Methamphetamine-Related Morbidity
Office of National Drug Control Policy (2014) reported that the number of druginduced deaths (DIDs) in the United States for 2010 alone was 40, 393, and that DIDs
increased significantly in the period between 1999 and 2010. Specifically, the authors
report that the rate increased from 6.8 per100, 000 persons to 12.9 per 100, 000 persons
between 1999 and 2010. Notably, these are deaths related to accidental poisoning and
overdose only, without including other drug-related deaths such as accidents, homicides,
and infectious diseases.
Conversely, Calcaterra and Binswanger (2013) observed that the trend of
psychostimulant-related deaths in U.S is equally alarming. According to the authors,
psychostimulant-related deaths, which are largely attributed to methamphetamine and
amphetamines, increased threefold between 1999 and 2005. Although these deaths are
reported to have reduced between 2006 and 2008, the authors reported a rebound
henceforth. Precisely, increase between 1999 and 2005 was 0.37/100, 000 to 1.05/100,
000 while the 2009 rate stood at 0.97/100, 000 (Calcaterra & Binswanger, 2013).
Importantly, the researchers used a nationwide database, which gives credibility to the
figures given. Unequivocally, adding other methamphetamine-related deaths such as
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HIV/AIDS related, accidents, and homicide may increase the figures grossly, which
affirms that methamphetamine is a leading killer in U.S that cannot be ignored.
Conclusion
In order to inform and quantify the purpose for this study, this chapter reviewed
several studies that are related to or contrary to the subject of the study. The issues that
are addressed by most of the studies comprised of the different reasons for drug or
substance abuse. The studies were based on gender, the gender differences in responses
to treatment of the methamphetamine abusers, the factors affecting the different genders
in responding to the long-term treatment programs, and the diverse treatment needs
required by the different genders in long-term drug abuse treatment programs. This
chapter further reviewed literature on relapse during and after treatment, and treatment
outcomes all of which provided important insight in to the subject and purpose of the
current study. Additionally, the literature review further provided a broader
understanding of the research study subject and the various research works that are
related to this study.
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Chapter 3: Research Method
Introduction
Usually, research methodology is taken to signify a plan that directs an inquiry or
an investigation. It can also be defined as a scientific and systematic probe to establish a
remedy to a problem or develop entirely new knowledge (Kumar, 2005). Creswell (2009)
posited that a comprehensive and precise methodology is essential for a valid and
acceptable research. According to the authors, such a methodology is a product of the
researcher’s stance of philosophy and an understanding of the question under study
(2009). This can be explained from the perspective that different researchers belong to
different schools of thought regarding validity, reliability, accuracy and acceptability of
research methods, which in turn influence processes involved in undertaking a research.
As such, it is clear that philosophy intersects research methods at the point where it
criticizes the techniques adopted. Specifically, philosophy answers the following
questions: What is the validity of the problem under study? What is valid and/or reliable
data? And how is reliable data collected, analyzed and reported?
Therefore, this chapter outlines the philosophy articulated by the researcher in
undertaking feasibility study and describes the research design, research strategies, and
variables of the study, instruments used in the study, sampling technique, data collection
and data analysis.
Research Philosophy
Philosophy in research is stratified in multifold categories that include social
constructivist, pragmatic, positivist, and participatory (Wu, 2014). Considering the nature
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of the subject, which mostly focused on human health and liberty from methamphetamine
abuse, the research methodology aligned on reality, practicality, comprehension of
research subjects, and evidence. In that context, the school of epistemology recognized as
realism, pragmatism, and ontology of positivist empiricism formed the philosophical
framework directing this study. This philosophical framework requires that reality should
be observed from a direct and objective manner. At no expense, should the truth be
inferred through human subjectivity (Wu, 2014). Subsequently, this study was delivered
based on truth supported by acceptably acquired and analyzed evidence.
From the ideology of ontology encompassed in positivist ontology, Angen (2002)
posited that the environment of a phenomenon is essential in understanding. Also, Hays
and Singh (2011) stated that a researcher’s perception on the subject of investigation is
influenced by his knowledge on the subject. Explicitly, this kind of phenomenon is
common in daily activities as can be shown by an example. People from different ethnic
and cultural backgrounds have traits, beliefs, and traditions that are unique to their
cultures. As such, it implies that men and women, due to their biological and social
differences, exhibit different behaviors under abusive use of methamphetamine and
corresponding treatments. Therefore, comprehending this perspective significantly
contributed to a realistic and practical study.
Nevertheless, realism is embodied in the opinion that knowledge is essential in
acknowledging the truth attached to a phenomenon (Hay & Singh, 2011). This has the
implication that the level of truth is determined by the extent of knowledge available
about the subject. This ideology was used in establishing the truth behind the abuse and
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treatment of methamphetamine through mining knowledge from sets of empirical
process.
Research Design
According to Hussey and Hussey (1997) and Mouton (2001), designing a social
research study is an in-depth process that requires a researcher to map out the strategies
effectively and systematically s they will employ. Mouton (2001) defines research design
as a “logical plan for getting from here to there, where here is the initial set of questions
to be answered by the participants and there is some set of conclusions derived from the
findings” (p. 47). Therefore, research design serves as a basis of obtaining relevant data
from which a researcher can effectively draw his or her conclusions. This kind of logical
plan was articulated from the research philosophies governing the researcher’s
understanding of the appropriate method. From the philosophy of realism (epistemology),
pragmatism and ontology (positivist empiricism), I settled on mixed method research
entailing both quantitative and qualitative research methods.
Quantitative research methods comprised of questionnaire surveys while
qualitative methods involved interviews and archival methods. The questionnaire survey
involved use of participant’s progressive self-reports that were administered using
questionnaires B, C, D, and E as predefined in the appendix. Conversely, self-reports
were complemented with the doctor’s report on progress to arrive at a more
comprehensive and all-inclusive measurement. Notably, differences that arose between
patients’ self-report and doctors’ reports were significant, which prompted a closer and
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critical monitoring of the patients to establish the exact situation. Monitoring was made
possible by organization of the study that incorporated a period of 6 months follow up.
A prominent type of quantitative technique that has been employed in the past
with outstanding results is California treatment Outcome Project (CalTOP) (Grella, Hser,
Teruya, & Evans, 2005; Rawson, 2004). The technique involved identifying and
categorizing the participants according to their counties of origin and other parameters
such as gender, and commitment to CalTOP (Grella, Hser, Teruya, & Evans, 2005). In
other words, CalTOP entailed provision of treatment in a focused group set up within
various treatment sites identified prior to commencement of a study. In relation to this,
the current study was constrained to gender as the main determinant of reporting the
findings.
I scheduled periodical interviews with patients to discuss their progress. It is also
important to note that the patients were provided with verbal or dialogue support when
responding to the questionnaire survey. This did not only assist the participants in
understanding the questions and clearly responding to them, but also provided an
opportunity that enabled them to express their feelings through body gestures and
movements.
It is imperative to note that mixed method research is an effective research
methodology based on the principle of triangulation (Cresswell, 2009). Cresswell (2009)
asserted that integration of multiple methods provides an opportunity for individual
methods to counteract weaknesses of each other. For example, the questionnaires are
suitable for obtaining information from a large population and thus act as good basis to
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generalize the representative findings on the entire population. However, interviews are
not suitable for large populations owing to the challenges of identifying willing
participants, scheduling meetings, recording information, and analyzing collected data.
Importantly, interviews provide an informed background to develop proper
questionnaires and seek clarity that cannot otherwise be expressed through the
questionnaires. Additionally, questionnaires are prone to be inaccurate and biased
(produce tailored results) whereas interviews have high propensity of providing authentic
data due to direct contact (Anglin, 2000). Succinctly, this rationalizes the need for
triangulation. Moreover, scholars agree triangulation avails most reliable research results
(Anglin, 2000).
Reliability and validity are key concepts that dictate worth, authenticity and
acceptability of a study (Anglin, 2000). According to Anglin (2000), validity is defined as
the propensity of reporting the real data. Creswell (2009) defined reliability as the
tendency of different researchers settling at the same results for the same phenomenon
regardless of the methods used. Reliability has also raised concerns in qualitative
research because it is difficult to establish the level of similarity between unstructured
studies. This may influence the methods used and thus cause inconsistencies in the
research process. I ensured reliability in this study through providing evidence and
concrete description of events and settings in the research.
Furthermore, the design is also descriptive and exploratory in terms of output.
Explorative studies are characterized by limited information regarding the subjects under
study and in most cases, involve study of new or enhanced aspect of a phenomenon
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(Hays & Singh, 2011). This study was considered explorative as it involved a critical
concept that is not exhausted in research- the significance of gender differences in
methamphetamine abuse and treatment of its addiction. Conversely, Hays and Singh
(2011) labeled descriptive research as one that uses qualities to define a subject without
necessarily giving explanations on the nature of some variables. As well, this study was
descriptive since it targeted to define circumstances surrounding gender differences in
treatment of patients who are addicted to methamphetamine.
Research Strategies
According to Cresswell (2009), research strategies refer to measures undertaken
to ensure the study is successful. This study was an integration of multiple stages and
methods of data collection and analysis. Institutional Review Board (IRB) approval was
granted prior to any data collection process. IRB approval number: 05-31-16-0081195. It
was thus essential to organize an extensive plan and strategize to ensure all details were
covered and that the correct data was acquired, analyzed, and reported. Importantly, the
current study was carried out in three phases and over 6-months involving extensive
follow-up activities and data collection.
This study applied a method similar to California treatment Outcome Project
(CalTOP) in meeting the research objectives, especially determining gender disparities in
abuse and treatment of addiction from methamphetamine. Originally, the principle
objective of CalTOP was to institute, implement, and pilot a system intended to monitor
the outcome of treatment efforts and to improve the existing management system in
Alcohol and Drug Programs (ADP). In the context of this study, CalTOP was employed
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to engender information from participants drawn from diverse areas in Montreal, Canada.
Specifically, I anticipated a wide inclusion of participants from several geographical
locations, ranging from central, northern, and southern regions of California.
The Impact residential program was identified as the case study rehabilitation
institution that provided the list of monitored patients. The provider sites were equipped
with treatment facilities and staff to minimize cost and maximize efficiency in conducting
the focus groups. Within 1 week following admission into the rehabilitation center, I
approached the patients and informed them about the research project.
Before the collection of data, I completed a suitability assessment on the
respondents to determine their ability to understand the questions and give honest
responses. Qualified respondents signed a consent form that indicated their acceptance in
taking part in provision of data for the research. Elaborate details on objectives and
methodology of the study were explained in the consent form in which the principle of
voluntary participation with guaranteed exit-at-will with no consequences was
emphasized. In undertaking the study, I had to abide by certain ethical issues. First, the
participants were assured that their privacy would be respected and that any information
collected in the process would be kept confidential. The patients’ names or personal
identification details were not included in the series of records collected. I assigned
unique codes to the participants that were used for follow up on the patients. With each
participant’s anonymity safeguarded, the participants’ background information collected
served as a basis for knowing the unique needs of each participant and helped to promote
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the ethical mandate of causing no physical or psychological harm to the respondent
(Farley, 2014).
Treatment modality entailed a multimodal treatment orientation that focused on
increased awareness of the negative consequences of substance abuse, improved social
adjustment, personal autonomy from methamphetamine addiction, and aftercare
involvement. Importantly, participants received standard aftercare provided by the
rehabilitation center, which involved three treatment modalities provided in three phases:
intake, midprogram, and towards the successful completion of the program. In addition to
the normal aftercare programs offered at the rehabilitation center, the participants were
further randomized to participate in either a 10-step facilitation aftercare program or in a
structured program for the prevention of relapse.
These two aftercare programs had certain common features. Firstly, they were
both administered in a 12-week, 60-minute closed group format, with participants
forming groups of five to 10 participants. Secondly, a manualized format was employed
by highly trained counselors to administer both interventions to the participants. The
group meetings, provided in the standard aftercare environment took 12 to 14 weeks and
were held at Impact residential programs. In the group set-up environment, either one or
two therapists were involved in administering psychosocial support to patients with social
reintegration (for example, family and employment), relapse, and craving problems. The
counselors also coordinated issues concerning health, access to ancillary services as well
as psychological adjustment. These services, although voluntary, were recommended for
all participants.
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The analysis process was done using both qualitative and quantitative techniques
with the aim of assessing how different genders responded to treatment. Information
engendered in the focus group discussion was used in the data analysis process using a
list of primary codes and subcodes derived from the topic and themes that emerged from
the focus groups. Transcripts were then coded and organized in order to analyze their
content using a qualitative software program, the ATLAS.ti (Klenke, 2008). Detailed
information regarding the specific processes of the research methodology is detailed
under the following sections: data collection, sampling methods, research variables and
the data analysis.
Research Variables and Instrument
Research variables are termed as those factors that investigators think will be
affected in the study and can be measured (Craighead & Nemeroff, 2002). I relied on
research variables coined from the researcher’s professional experience in substance
abuse, reconnaissance interviews with the specialists and literature review. It is important
to note that they were aligned to the research questions and objectives to facilitate the
achievement of the study objectives. The variables were intended to offer information
that could be used to formulate effective approaches to the treatment of female
methamphetamine addicts. Usually, research variables are categorized into 3 categories,
namely the dependent, independent variables and status variables.
The independent variables are those factors that are varied in an experiment or
research to see whether the outcomes are significantly changing. Conversely, the
outcomes that change as a result of changes in independent variables are referred to as the
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dependent variables (Creswell, 2009). The variables that cannot be varied by the
researcher are identified as status variables and they are majorly composed of
demographic variables. Variables used in this study are listed Table 1 below.
Table 1
Research Variables
Category
Respondent
assessment

Demographics
Reasons for use of
methamphetamine

Variables
Questionnaire
age-group, selfA
definition or
expression,
responsibility, social
or psychological
functioning
Gender, Age, Marital
B
status, education level
Reduced fatigue (BB
Q8-a), Increased
attention (B-Q8-b),
Wakefulness (B-Q8c), increased activity
(B-Q8-d), Better Sex
(B-Q8-e), to escape
the poignant or
emotional distress that
is caused by the
occurrence of
victimization or
sexual abuse (B-Q8f), Married couples
Influenced by their
partners (B-Q8-g),
Reduce stress (B-Q8h), Self-medication
(B-Q8-i), Socialize
(B-Q8-j), Emotional
problems (B-Q8-k)
and Weight loss (BQ8-l).

Authors

(Table continues)
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Category
Socio-logical
functioning

Variables
Other effects were
categorized as
psychological
functioning and
included Depression
(B-Q12-a), decision
making (B-Q12-b),
risk taking (B-Q12c) and criminal
thinking (B-Q12-d).

Pattern of Drug
Abuse

Advice from
Friends Medical
office (anxiety,
mood disorders, and
pain) Incitement
from the first use,
Incitement from
your partner (for the
married or engaged
or dating),
consumption rate
Current health/
continue with
treatment

B

Facilities, support
team

C, D

Out-patient,
In-patient
Rehabilitation,
traditional
outpatient (OTP)
treatments
therapeutic,
community program
called clean lifestyle
(CLIFF-TC
Medication,
Stimulant treatment

C

Patient’s condition

Evaluation of
progress, support
team, the institution
Perception on
Treatment
Treatment types

Questionnaire

Authors

B

(Table continues)
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Category
Engagement in
treatment
(Motivation)

Engagement in
treatment
(Deterents)

Variables
Questionnaire
family and society
C
factor,
The need for
pregnancy for
women into seeking
treatment?
, Work , Awareness
/ support from the
society
Stigma, Parenting
C
and childcare e.g.
the lack of
surrogates to carry
out their
responsibilities,
Medical Conditions
, vocational or
educational training/
Work
Instrumentation and Materials

Authors
Rowan-Szal et al.,
2009).

Factors such as treatment retention, patient intake and follow up, addiction
severity index (ASI), and treatment service review (TSR) need to be taken into
consideration in order to ascertain pertinent factors that are likely to cause addiction to
methamphetamine. Such factors may help in the determination of the ideal treatment
approaches that match the needs of the either genders (Rawson, 2004). The study used
various instruments to collect information from participants in different stages of
treatment. Some of these instruments include: Respondent’s suitability guide,
participant’s methamphetamine abuse condition, treatment, progress, and summative
evaluation.
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Questionnaire A: Respondent’s suitability assessment guide.
This was the first research instrument to be administered. This questionnaire
guide was meant to allow the research facilitator to establish the suitability of the
respondent in making informed consent regarding the study. As such, the study
conformed to the standard research ethics in protecting participants from unintended
harm from the research due to mental instability related to drugs or otherwise. In
achieving this, the research designed a criterion upon which each potential participant
was screened. The factors incorporated were gender, age-group, self-definition or
expression, responsibility, social functioning, psychological functioning, and period of
stay at the rehabilitation which corresponds to the level of detoxification.
Specifically, all participants were either above the age of 18 years or represented
by a parent or guardian if underage. Besides, mature participants were required to clearly
represent themselves; to be occupied with responsibilities such as family, education or
work; and to have no mental illness. Importantly, participants must have taken more than
1 week at the rehabilitation center, ostensibly to have been oriented to the treatment
program and perhaps attained some basic stabilization. From the list of participants
matching the predefined criterion, a sample of 50 males and 50 females, which needed to
be done by convenient sampling was expected.
Questionnaire B: Participant’s abuse condition assessment.
This questionnaire was intended to report the participant’s abuse condition on
such areas as operational state of health, reasons for abusing methamphetamine, patterns
of drug abuse, and consumption rate and its effects. Specifically, questionnaire B
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incorporated the Addiction Severity index (ASI) to collect pertinent information such as
participants’ socio-demographic background, employment, age, education, and marital
status. Originally, ASI is essentially a semi-structured interview protocol that is
employed in the assessment of a wide range of addiction related behaviors and
consequences (Caetano & Raspberry, 2000). The ASI was used to compute composite
scores related to severity of methamphetamine use by the participants over the past 60
days. The instrument was also used to derive five other psychological functioning
subscales pertaining to employment, family, medical, legal and psychiatric severity.
Additionally, the study questionnaire incorporated the Checklist-90 (SCL-90),
which is a viable instrument used to assess the participants’ psychological symptoms.
SCL-90 has been employed successfully as a screening device in identifying and
assessing psychological problems in previous treatment studies involving drug and
alcohol abusers (Weissner, McCarty & Schmidt, 1999). The instrument is selfadministered and provides three general symptom severity indices and 9 clinical scales.
The aggregate scores computed in the nine clinical scales of SCL-90 were then computed
in a Global Severity Index (GSI), which served as a dependent variable in successive
analysis.
Another important aspect that was used in the study questionnaire is the Timeline
Follow-Back (TFLB), which functions as an aid to recall and will assist the participants
in recalling instances of methamphetamine use on a daily basis for a period of 60 days.
Given the quantity and frequency data that TFLB yields, the instrument is effective in
minimizing incidences of underreporting use of substance (Young, Gardner & Dennis,
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1998). The study drew dependent variables from the number of days the participants
engaged in substance use and the number of days he or she abstained from the drug
before the first relapse.
Questionnaire C: Treatment.
This tool reported on the status of treatment methods or types as perceived by the
client and the experience acquired at the impact residential facility. Besides, motivators
of seeking the treatment as well as the deterrents were presented in the questionnaire.
This questionnaire was administered to patients who had undergone treatment sessions.
Questionnaire D: Progress.
This questionnaire was meant to track the progress of the participants as they
underwent treatment. Factors considered here included rating of the operational
treatment, and the willingness to continue with treatment at different stages, that is, at the
beginning, after 3 months, and after six months.
Another structured interview protocol that formed an appropriate component in
diagnosing methamphetamine abuse is the non-patient version of the Structured Clinical
interview for DSM-III-R (SCID-NP) (Klenke, 2008). A major component of this
structured interview protocol is the diagnostic features for psychiatric conditions
contained in DSM-IV- TR. However, this study focused on the sections of the protocol
that have a diagnostic classification of substance dependence or abuse disorders. This
criterion is on Axis I of the structured interview protocol.
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Questionnaire E: Summative evaluation.
This questionnaire was intended to report the overall progress of the treatment
program. The participant’s opinion on satisfaction of the institution and its attendants was
sought through this tool. The participants were also requested to list the strengths they
noted, the challenges they experienced and the recommendation they would make to
improve the entire experience.
Setting and Sample Size Determination
Sampling is the process of selecting participants (Craighead & Nemeroff, 2002).
Table 2 below adapted from Corbetta (2003) indicate appropriate sample size for
different populations. However, there are exceptions to selecting the recommended
sample size. According to Monette, Sullivan, and Dejong (2010), a researcher should
report both the appropriate sample sizes along with the sample sizes actually used in the
study in the event that the researcher faces constraints dictating use of inadequate sample
sizes due to practical and/or statistical reasons. Possible constraints according to the
authors are budget, time, personnel and other resource limitation.
Table 2
Sample Size Determination Table as Per Corbetta (2003)
Sample Size
Continuous data (margin of error=0.03)
alpha=0.05
Population Size alpha=0.10
t= 1.65
t=1.96
100
46
55
200
59
75
300
65
85
400
69
92
500
72
96
600
73
100

alpha=0.01
t=2.58
68
102
123
137
147
155

50
700
800
900
1,000
1,500
2,000
4,000
6,000
8,000
10,000

75
76
76
77
79
83
83
83
83
83

102
104
105
106
110
112
119
119
119
119

161
166
166
173
183
189
198
209
209
209

In this study, the researcher used a sample size of 50 male and 50 female
participants who were drawn randomly from Impact residential Programs. Random
sampling was used in this study to select the 50 male and 50 female participants from the
two treatment and rehabilitation centers.
Inclusion Criteria
The following inclusion criteria were mandatory for all patients who were willing
to participate. Firstly, they had to attain the requisite criteria for abuse or dependence on
psychoactive substance, particularly methamphetamine. This was ascertained from a
structured interview for DSM-IV-TR (SCID). Secondly, they had to be able to read and
write in English. This eased the process of responding to the research instruments such as
questionnaires with minimal assistance from the facilitator. Thirdly, they had to be
residing within 60 kilometer radius of Montreal for easy monitoring and check-ups
especially in after-care programs.
Importantly, inclusion also adhered to tenets of ethics for research involving
human respondents including availability and willingness to participate. All participants’
rehabilitation counselors and program directors were informed about the general aspects
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of this study and permission was granted to recruit volunteer participants. Participants
were drawn from three phases of the treatment: Intake, mid-program and towards the
successful completion of the program. Informed consent was obtained from each
participant prior to any form of exposure to the study, which protected their autonomy.
Besides, confidentiality was assured and observed throughout the study.
Data Collection
The collection of data from the participants and the doctors was intended to last a
period of six months divided into three phases. The first phase of the data collection
process involved assessing the condition of the patients in order to provide a basis for
evaluating their progress after some time. In that regard, Questionnaire B (Respondents’
condition assessment) attached at as the Appendix B was administered with the help of a
facilitator. The facilitator’s role was to provide clarity and explanation on the aspects of
the questions that were challenging to the respondents. The data collected in this phase
included: Demographics (B-Q1, B-Q2, B-Q3, B-Q4), health (Q5, Q6, Q7), reasons for
using methamphetamine (Q8), pattern of drug abuse (Q9, Q10), and effects of
methamphetamine (Q11, Q12).
The second phase of the data collection process involved collecting information
on the perception of the drug abuse victims on suitability of different treatment methods
and impact of the administered treatment on their conditions. In question C-Q1, the
participants were asked whether they had sought any treatment before and thereafter
asked to rate the current treatment (C-Q2). Additional information collected included
motivations that lead to seeking of medical attention (C-Q4) and deterrents from seeking
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medical attention (C-Q5). Importantly, assessment of all participants on a
multidimensional basis occurred periodically 3 times: Immediately upon initial admission
for intensive treatment (D-Q1-a), after successful completion of 3 months in intensive
treatment (D-Q1-b), and after completion of the entire six months intensive treatment (DQ1-c). At the different designated periods, the participant was asked whether they were
willing to continue with the program (D-Q2) in order to determine their recovery and
relapse rate. The facilities at the institution were evaluated through question D-Q3.
Lastly, the third phase entailed summative evaluation of the participant’s
satisfaction with the treatment (E-Q1) and satisfaction with the support (E-Q2).
Moreover, the participants were requested to provide the strengths they noted, the
challenges they faced and the recommendations that would help improve the entire
experience.
Data Analysis
The data analysis was undertaken in accordance with the research questions. In
analyzing the results of the study, the researcher used quantitative data analysis method.
Quantitative research focuses on analysis of numerical data (Klenke, 2008). Specifically,
the investigators employ positivist claims in an attempt to infer behavior and establish
comparisons between cause and effect, development of questions and hypotheses,
observation and measurement of variables, and testing of various theories (Weissner,
McCarty, & Schmidt, 1999). In quantitative study, the magnitude of a variable on another
one is established through isolation and verification of the causal relation between them.
Quantitative research also provides researchers with a viable option of determining the
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most appropriate variables to investigate in order to produce reliable and valid outcome
(Craighead & Nemeroff, 2007).
Descriptive statistics were also used to capture the opinions and attitudes of the
participants as obtained via descriptive questions. Specifically, median and quartiles were
used to help describe outcome of the treatment program in case there was a non-normal
distribution in the outcome of the treatment study. Given the nature of this descriptive
study, the researcher relied on bar heavily to provide graphical summary of quantitative
data.
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Chapter 4: Results
Introduction
The study was successfully carried out over a period of 6 months. It is important
to note that it had three main phases took place at different periods in a systematic
manner. The first phase was designated to help identify the right participants whereas the
second phase involved probing for the demographics, methamphetamine abuse patterns,
reasons for abuse, and effects of methamphetamine. The third phase concentrated on the
treatment process touching on such issues as the effectiveness of various treatment
methods, suitability of the operational treatment, and the perception of the respondents
regarding other aspects of treatment. Generally, the research succeeded in getting 100
participants, 50 males and 50 females from the group of 158 persons. The rest of the
details are as detailed herein.
Phase 1
This was the core stage of the entire feasibility study as it was meant to identify
methamphetamine users who were legible to participate in the study. This involved
contacting a large number of respondents with the destined aim of acquiring at least 50
female and 50 male participants. They were evaluated based on gender, social
functioning, psychological functioning, ability to make informed consent, and above all
willingness to participate in the study. A total of 158 patients were contacted, but 38 were
unsuitable for the current study due to use of multiple drugs that could impair their level
of functioning and cognition. However, I settled on the initial sample of 50 females and
50 males for the study.

55
Phase 2
This phase of the data analysis reports on the demographics trends among the
methamphetamine users, methamphetamine abuse patterns, reasons for abuse, and effects
of methamphetamine.
Demographics
Age. Respondents in this study were 50 male and 50 female as shown in Figure 1.
The respondents were of different age groups, with an age-range of 30-40 years being the
dominant group. Among the female respondents, participants aged 13-18 years made up
10 % of the respondents, those aged 19-30 years constituted 24%, those aged 31-40 years
constituted 40% of the respondents, while those aged above 40 years were 26% of the
total respondents. Conversely, male respondents aged 13-18 years were 10% of the total
male respondents, those aged 19-30 years comprised 26%, and participants aged 31-40
years were 50%, while those aged above 40 years comprised of 14%.

Figure 1. Participants’ age distribution
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Marital status. The statistics in the Figure 2 indicate that most females who
abuse methamphetamines are either divorced or single while the majority male
methamphetamine users are married. Specifically, both the divorced and single female
abusers comprised of 26% while both married and minor female abusers constituted of
24% of the total female respondents (N=50). Conversely, 24% male respondents were
divorced, 28% married, 24% single, and 24% minor (N=50). Hence, majority of female
methamphetamine abusers were single and/or divorced whereas majority of male
methamphetamine abusers were married as shown in Figure 2 below.

Figure 2. Respondents’ marital status
Education level. Figure 3, below, is a representation of the respondents’
education level. A majority (50%) of the participants (N=100) were pursuing their first
degree or diploma in a college or university, 34% were secondary school students, and
16% postgraduate students. However, education level also varied with gender of the
respondent with an obvious bias towards men being more educated. Specifically, 76% of
male methamphetamine abusers were college or university students, 8% were secondary
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schools students, while 16% were post-graduate students. Hence, it suffices to say that
more male methamphetamine users were educated as compared to females.

Figure 3. Participants’ educational level
Childhood complications. An analysis of occurrence of childhood complications
such as physical abuse, sexual abuse, and negligence among methamphetamine users is
shown in Figure 4 below. The figure indicates that 60% of female methamphetamine
abusers had childhood complications as compared to 42% of male methamphetamine
abusers. Given that childhood complications and drug abuse are correlated, the researcher
went ahead to obtain participant self-report of the severity of childhood complications on
a Likert scale of agreed, neutral, disagreed, and strongly disagreed. Notably, response
also differed with gender because 16% of females agreed, 34% were neutral, 10%
disagreed, and 40% strongly disagreed as compared to 8% of men who agreed, 18%
neutral, 16% disagreed, and 58% strongly disagreed that childhood complications were
severe. These figures are indicated in Figure 5 below.
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Figure 4. Childhood complications

Figure 5. Severity of childhood complications
The researcher sought to know the current health status of the abusers as at
enrolment to offer baseline for monitoring through treatment. Among the female
participants, 34% agreed that their current health status was good; an equivalent
proportion (34%) disagreed with the claim, while the remaining 32% remained neutral.
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Conversely, majority (66%) of the male respondents remained neutral about the condition
of their current health, with 16% agreeing that their health is good and 18% indicating
that their current health was not good.

Figure 6. Current health status
Reasons for Using Methamphetamine
Figures 7, 8, and 9 indicate analysis of the reasons why the respondents used
methamphetamine. Figure 7 focuses on four reasons: reduction of fatigue, increment of
attention, wakefulness, and increased activity. Notably, majority (90% females and 84%
males) respondents agreed to use of methamphetamine for reduced fatigue. Specifically,
66% (N=50) of females strongly agreed to methamphetamine use for reduced vis-à-vis
58% (N=50). The female respondents who remained neutral about the influence of the
drug on reduction of fatigue were 10% against 16% for the male respondents. The
remaining 24% of the female respondents and 26% of the male respondents generally
agreed to consumption of methamphetamine for reduced fatigue. Remarkably, not a
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single male or female respondent disagreed or strongly disagreed with priori that they
consumed methamphetamine to reduce fatigue.
All the respondents indicated that they used methamphetamine to improve their
levels of attentiveness. Interestingly, 50% of both male and female respondents agreed to
use of methamphetamine to increase attentiveness while a similar proportion for both
genders strongly agreed to methamphetamine use for the same reason. Hence, no
respondent in either gender remained neutral, disagreed, or strongly disagreed to use of
methamphetamine for increased attention.
Similarly, majority respondents either agreed or strongly agreed to using
methamphetamine to remain awake. Precisely, 48% of females and 26% of males agreed
to use of methamphetamine to achieve wakefulness. Notably, more females (52%) than
males (48%) strongly agreed to methamphetamine use for the purpose of wakefulness.
Importantly, 26% of male respondents disagreed to use of the drug for the sake of
wakefulness. Hence, no respondent remained neutral or strongly disagreed, but some men
disagreed as illustrated above.
All the respondents accepted the claim that they consumed the drug to ensure an
increase in activity. For the female respondents, 58% indicated strong agreement to the
fact that they consumed the drug to increase the levels at which they performed activities
while 42% indicated strong agreement. No female respondent gave a neutral response or
a disagreement to the claim. The male respondents on the other hand had 66% of the
respondents agree to the fact that they consume the drug to enhance the rate at which they
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perform activities while 34% of the respondents strongly agreed. No male respondents
gave a neutral or a disagreement response.

Figure 7. Reasons for using methamphetamine part 1
Figure 8 focuses on four additional reasons as to why respondents used
methamphetamine. The four reasons are better sex, escape from emotional distress of
sexual abuse, influence by marriage partners, and reduction of stress. Regarding better
sex, majority male respondents agreed that the drug gave them better sex. The male
respondents who gave a strong agreement to the claim that they use the drug to get better
sex were 84% while the remainder agreed to using methamphetamine for better sex.
There were no male respondents with a disagreement or a neutral response. Conversely,
40% of the female respondents gave a strong agreement to the fact that they consumed
the drug to get better sex and 36% simply agreed to the claim. Although there were no
neutral responses among females, 24% of the female respondents strongly disagreed to
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the fact that they used methamphetamine in order to get better sex. Hence, this reason
appears to drive drug use among men than women.
There was generally a mixed reaction regarding consumption methamphetamine
as a way of escaping emotional distress from sex abuse. Notably, there were no neutral
responses from either males or females. Among the female respondents, 24% strongly
disagreed to the claim while a similar proportion agreed to this claim. Moreover, a further
16% agreed while 36% disagreed to methamphetamine use to escape distress from sexual
abuse. Conversely, the 88% of males strongly disagreed to the fact that they consumed
methamphetamine to escape emotional distress emanating from sexual abuse, 8% agreed,
while 4% strongly agreed to the claim. Hence, more females than males appear to use
methamphetamine as an escape to sexual abuse.
A unique observation was made with respect to partner influence in
methamphetamine use. Precisely, no male or female respondent agreed or disagreed to
this priori, but the majority strongly disagreed. While 16% of the female respondents and
8% of the male respondents equally remained neutral and strongly agreed respectively,
68% of female respondents and 84% of male respondents strongly disagreed.
Lastly, no respondent disagreed to the claim that they consumed the
methamphetamine to reduce the levels of stress. The respondents who remained neutral
to the claim were 18% of the female respondents and 34% of the male respondents.
Female respondents who strongly agreed to the claim were 24% while the other 58%
agreed to use of methamphetamine to reduce stress. The phenomenon was almost similar
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among male respondents because 24% strongly agreed while 42% agreed to
methamphetamine use to reduce stress.

Figure 8. Reasons for using methamphetamine part 2
Figure 9 focuses on the last four factors thought to lead to consumption of
methamphetamine. Beginning with methamphetamine use as a self-medication, no
respondent agreed or disagreed to this claim in either gender. However, 40% of the
female respondents remained neutral, 26% strongly agreed, while 34% strongly disagreed
to medicating themselves with methamphetamine. Conversely, 58% of male respondents
were neutral, none strongly agreed, while 42% strongly disagreed to medicating
themselves with methamphetamine.
Similarly, response to consumption of methamphetamine in order to socialize had
a mixed picture. Precisely, no male respondents remained neutral about the claim while
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26% of the female respondents remained neutral. Besides, no respondent strongly agreed
to using methamphetamine for the purpose of socialization between the genders.
However, 48% of females against 50% males agreed to methamphetamine use for the
purpose of socialization, 16% females against 34% males disagreed to having used
methamphetamine for the purpose of socialization, while 10% females against 16% males
strongly disagreed to this allegation.
With respect to methamphetamine use secondary to emotional problems, majority
male respondents agreed while most of the female respondents remained neutral.
Precisely, 50% of males agreed, only 8% remained neutral, and 42% strongly disagreed
to methamphetamine use as a panacea to emotional problems. Conversely, 24% of
females agreed to have used methamphetamine due to emotional problems, 40%
remained neutral to this claim, 26% agreed strongly, and 10% disagreed strongly to this
priori.
The very last reason for using methamphetamine that was assessed in this study
was weight loss, which appeared to work for females as compared to male respondents.
Specifically, majority (92%) of male respondents disagreed to using methamphetamine
with an aim of reducing body weight with the remaining 8% strongly agreeing to this
claim. Notably, the scenario was much different for female respondents because 26%
agreed to have used methamphetamine mainly for weight loss while 16% agreed
strongly. Specifically, only 34% of females strongly disagreed to have targeted weight
loss while using methamphetamine while almost half (40%) the respondents remained
neutral.

65

Figure 9. Reasons for using methamphetamine part 3
Source of knowledge on methamphetamine
Figure 10 gives a breakdown of initial source of knowledge on methamphetamine
with a focus on friends, medical office, partner, and incitement after initial use. Of all the
possible sources of methamphetamine-related information, advice from friends showed a
more positive response with no male or female respondent indicating any form of
disagreement to the claim. Although no female respondent indicated strong agreement to
having started methamphetamine abuse after learning about it from friends, 26% of the
male respondents indicated strong agreement. The respondents who indicated normal
agreement were 48% of the female respondents and 50% of the male respondents. The
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remaining 52% of the female respondents and 24% of the male respondents remained
neutral to this claim.
There were no respondents who remained neutral or strongly agreed that their
consumption resulted from the use of methamphetamine from a medical office, that is,
that the initial contact was medical prescription. This element is a reflection of
dependence, where a drug was medically prescribed but a patient develops dependence
and progresses to abuse. Notably more females than males agreed to have gotten their
first dose from a medical office. Precisely, 36% of females and 16% of males agreed to
have initially gotten methamphetamine from a medical office. Those who strongly
disagreed were 24% of the female respondents and 50% of the male respondents. The
other 40% of the female respondents and 34% of the male respondents disagreed to the
claim.
Conspicuously, no respondent even between genders strongly agreed to having
abused methamphetamine due to incitement from the first use regardless of source.
However, 26% of female users agreed that their abuse resulted from first use
incitement/experience. No male respondent agreed that the actions resulted from first use
incitements. Besides, 10% of the female users against 16% of the male users strongly
disagreed to the claim of addiction resulting from first use while 16% of the female users
and 34% of the male users disagreed. The remaining 48% of the female users and 50% of
the male users remained neutral about the claim.
There was a mixed reaction from the claim methamphetamine abuse resulted from
partner incitement. While 50% of the female users remained neutral about the claim, no
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male respondent was neutral. Notably, 16% of female respondents and 8% of male
respondents strongly agreed to the fact exposure leading to abuse resulted from influence
of partners. A similar proportion also disagreed to this claim. Conversely, 16% of the
female abusers against 60% of the male abusers strongly disagreed that their partners
influenced them to abusing methamphetamine. The remaining 24% of the male
respondents agreed that their partners influenced them into abusing methamphetamine.

Figure 10. Source of knowledge
Daily Consumption
Figure 11 indicates the analysis regarding the rate of daily consumption of
methamphetamine by the respondents. For the female respondents, 16% agreed that their
daily consumption was high, 24% disagreed, 50% remained neutral, and the other 10%
strongly disagreed that they had high daily consumption of the drug. Conversely, 8% of
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the male respondents agreed that they had high daily consumption of methamphetamine,
26% disagreed, 50% remained neutral, and 16% strongly disagreed that they had high
daily consumption of methamphetamine.

Figure 11. High daily consumption
Effects of Methamphetamine
Figure 12 focuses on internalized childhood problems, attempted suicide, skin
problems, and work related problems as examples of effects of methamphetamine on the
abusers. The effect of internalized childhood problems received mixed reactions from the
respondents, with neither the females nor the males indicating strong agreement to the
claim. Paradoxically, 42% of the female respondents and 8% of the male respondents
agreed to the fact that methamphetamine abuse resulted to internalized childhood
problems. Besides, 8% of the female respondents and 18% of the male respondents
strongly disagreed to the claim. Moreover, 10% female respondents and 42% male
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respondents disagreed with the idea that methamphetamine use lead to internalization of
childhood problems. The remaining 40% of female respondents and 32% of male
respondents indicated neutral response to the claim.
Similarly, attempted suicide as a consequence of methamphetamine use also
received mixed reaction from the respondents with a significant proportion disagreeing.
Specifically, 40% of the female respondents disagreed, 8% remained neutral, 16%
indicated strong agreement, and the remaining 36% indicated strong disagreement.
Conversely, 24% of male respondents agreed, 34% disagreed, 18% were neutral, 8%
strongly agreed, and 16% strongly disagreed.
Unlike the first two, skin diathesis as a consequence of methamphetamine use
received a general agreement among the respondents with no form of disagreement from
either the male or the female respondents. Those who remained neutral were 10% of the
female respondent and 16% of the male respondents. Normal agreement was recorded by
24% of the female respondents and 52% of the male respondents. The other 66% of the
female respondents and 32% of the male respondents agreed to the fact that
methamphetamine abuse resulted to skin problems.
Phenomenon of drug abuse leading to work-related problems is common, which
was also replicated in the current study. In fact, there were no neutral respondents among
both male and female, which replicated itself with respect to disagreement that
methamphetamine causes work-related problems. For the female respondents, 42%
recorded normal agreement to the claim, 24% recorded strong agreement, and the other
34% recorded strong disagreement to the claim. Conversely, 34% of the male
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respondents agreed to the fact that methamphetamine caused work related problems, 50%
recorded strong agreement, and 16 % recorded strong disagreement to the claim.

Figure 12. Effects of methamphetamine a
Figure 13 captures three additional effects of methamphetamine use namely
stroke and heart damage, psychosis, and damage of the nervous system. There were no
respondents who agreed to the fact that methamphetamine caused stroke and heart
problems. Besides, 42% of the female respondents and 32% of the male respondents
remained neutral to the claim. Additionally, 42% of the female respondents and 34% of
the male respondents strongly disagreed that methamphetamine may cause heart damage
and stroke. However, the other 16% of the female respondents and 34 % of the male
respondents disagreed to the claim.
The effect of psychosis had a mixed reaction from the respondents with a larger
proportion of respondents generally agreeing to the fact that methamphetamine abuse
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may cause psychosis. For the female respondents, 26% strongly agreed and 40% agreed
that methamphetamine abuse causes psychosis. Only 10% of the female respondents
strongly disagreed to the claim while the other 24% remained neutral. Conversely, 24%
of male respondents strongly agreed to the claim that methamphetamine abuse causes
psychosis, 34% agreed, 24% strongly disagreed, and 26% indicated disagreement.
The last effect of methamphetamine abuse that was assessed pertained to damage
of the nervous system. Notably, no respondent agreed or strongly disagreed to the claim
that methamphetamine abuse causes nervous damage. However, 10% of the female
respondents strongly disagreed to the claim, 42% agreed, while the other 48 % remained
neutral. Conversely, 16% of the male respondents strongly disagreed with the claim, 58%
indicated normal agreement while the other 26% remained neutral.

Figure 13. Effects of methamphetamine b
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Effect of Methamphetamine use on Social and Psychosocial Functioning
Figure 14 shows an analysis of effect of methamphetamine use on social and
psychosocial functioning with a focus on depression, decision making, risk-taking, and
criminal thinking. Conspicuously, there were no disagreements to the fact that the abuse
of the drugs caused depression. A significant proportion of female respondents 90%
strongly agreed while 10% agreed that methamphetamine use leads to depression.
Conversely, 58% and 42% of male respondents strongly agreed and agreed that
methamphetamine use leads to depression respectively.
In terms of methamphetamine affecting decision-making ability, 50% female
respondents remained neutral, 26% strongly agreed, 16% agreed, and 8% disagreed. On
the contrary, 34% male respondents agreed that methamphetamine use leads to impaired
decision-making capacity, 42% disagreed, and 24% remained neutral.
Literature indicates a strong correlation between drug abuse and risk-taking
behavior, which informed assessment of this variable in the current study. Remarkably,
66% of female respondents and 92% of male respondents agreed that methamphetamine
increased propensity to engage in risky behavior. Notably, only 8% of male respondents
against 20% of female respondents remained neutral.
Finally, there was a mixed reaction regarding criminal thinking and
methamphetamine use. For the females, 34% indicated normal agreement, 24% had
strong agreement, 16% indicated normal disagreement, and 26% remained neutral. For
the male respondents, 26% strongly disagreed, 8% indicated normal disagreement, and
66% indicated normal agreement to the claim.
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Figure 14. Effect on psychosocial functioning
Phase 3: Treatment
The researcher was interested to know how many of the respondents had
previously sought treatment for methamphetamine use as indicated in Figure 15. It was
noted that 50% of the female respondents and 76% of the male respondents had sought
treatment regarding their addiction. Conversely, 50% of female respondents and 24% of
male respondents had not sought for any form of treatment for their addiction to
methamphetamine.
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Figure 15. Proportion that sought treatment
Motivators to seek treatment
Literature indicates that early treatment is likely to reduce methamphetaminerelated morbidity and mortality. Figure 16 shows the analysis of the factors that
motivated the addicts to access treatment regarding their addiction. It analyses the
influence of the factors like family and society influence, need for pregnancy, work, and
awareness initiatives. Remarkably, all respondents agreed that family and society
influence made them seek treatment. Precisely, 42% of female respondents and 58% of
male respondents strongly agreed, while 58% of female respondents and 42% of male
respondents indicating agreed.
Majority of the respondents disagreed to the claim that the need for pregnancy
influenced them to seek treatment. Importantly, a majority (84%) of female respondents
strongly disagreed while the remaining 16% strongly agreement that pregnancy was the
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motivator to seeking treatment. The same question was relevant for male respondents in
as much as men do not carry pregnancies. Similarly, only 8% strongly agreement that
pregnancy pushed them to seek for treatment, 26% agreed, but 66% strongly disagreed.
In the context of work-related influence, female respondents had 42% remaining
neutral, 24% agreeing strongly, and 34% disagreeing strongly. Conversely, 26% of male
respondents agreed that work-related factors contributed to seeking treatment, 8%
remained neutral, 50% strongly agreed, and 16 % strongly disagreed.
Finally, all respondents agreed that community awareness made them seek
treatment. Specifically, 66% of the female respondents and 32% of the male respondents
strongly agreed while 34% of female respondents and 68% of male respondents agreed.
Therefore, it suffices to say that community awareness was perhaps the most important
factor.

Figure 16. Motivators to treatment
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Barriers to Seeking Treatment
Identifying barriers to health seeking behavior with respect to methamphetamine
abuse is equally fundamental in designing treatment programs. Figure 17 gives a
summary of factors such as stigma, parenting and childcare, medical co-morbidities, and
vocational or educational training. A larger number of the respondents agreed that stigma
was a significant barrier to seeking treatment. Specifically, 52% of female respondents
strongly agreed to the claim and 8% agreed while 16% disagreed and 24% disagreed
strongly. Conversely, 18% of males agreed and 74% strongly agreed while only 8%
disagreed that stigma was a barrier to health-seeking behavior.
The parenting and child care factor as a barrier to seeking treatment had more
females disagree. Specifically, only 8% of female respondents strongly agreed and 32%
agreed while a whole 60% disagreed that parenting and/or child care was barrier to
seeking treatment. Paradoxically, a significant proportion of male respondents appeared
to agree that child care and/or parenting was a barrier to seeking treatment. Specifically,
42% of males agreed and 18% agreed strongly while only 24% disagreed and 16%
disagreed strongly.
Analysis of medical conditions as barrier to seeking treatment had mixed reaction,
with majority of the males agreeing and majority of the females disagreeing. Precisely,
50% of the male respondents agreed to the claim, 8% remained neutral, 26% disagreed,
and the other 16% disagreed strongly. Conversely, 48% of the female respondents
disagreed, 10% strongly disagreed and the remaining 42% remained neutral.
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Finally, majority participants disagreed to the fact that vocational or educational
training prevented them from seeking treatment. Notably, only 10% of the female
respondents and 16% of the male respondents agreed to the claim. Those who disagreed
strongly included 74% of the female respondents against 50% of male respondents.
Although 26% of the male respondents remained neutral, 16% of female respondents and
8% of male respondents disagreed with the fact that training barred them from seeking
treatment.

Figure 17. Barriers to seeking treatment
Preferred Treatment Modality
Figure 18 shows the preference of the respondents with regard to the nature of
treatment. It analyses the treatment types that include outpatient, inpatient rehabilitation,
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traditional outpatient treatment, CLIFF-TC, medication, and stimulant treatment.
Coincidentally, 50% of the female respondents and 52% of the male respondents
preferred outpatient treatment while 24% of male respondents strongly preferred the
same treatment modality against none for females. Notably no respondent in either
gender was neutral to outpatient treatment as a preferred modality. Besides, 40% of
female respondents and 8% if male respondents disagreed were not for the opinion that
outpatient treatment for methamphetamine abuse is the method of preference while 10%
females and 16% males strongly disagreed to this notion.
In inpatient rehabilitation treatment modality, the female respondents indicated a
16% agreed to it as a preferred method, 50% disagreed, 16% strongly agreed, and 18%
strongly disagreed. Conversely, 34% of male methamphetamine abusers considered
inpatient treatment the preferred treatment modality, 24% disagreed, 8% strongly agreed,
and 34% strongly disagreed.
The third modality for which preference was assessed is the traditional OTC
method. Notably, majority of the respondents disagreed that OTC is a preferred method.
Specifically, 24% of the male respondents agreed, 16% disagreed strongly, and 60%
disagreed. On the other hand, 10% of the female respondents strongly disagreed, 66 %
disagreed, and the remaining 24% remained neutral. Results for OTC method differ with
those for CLIFF-TC method that had mixed reactions. Specifically, 42% of the female
respondents and 32% of male respondents were neutral, 16% females and 34% males
agreed, 18% females and 34% males disagreed strongly, while 24% females agreed
strongly
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The researcher also assessed preference to medication as a method of
methamphetamine treatment. Notably, majority (40%) female methamphetamine abusers
disagreed that medication was the preferred method of treatment with a further 18%
disagreeing strongly. Besides, 24% of female respondents agreed to medication as a
preferred treatment modality while 16% were neutral. Conversely, half of the male
respondents (50%) agreed to medication as a preferred treatment method, 8% remained
neutral, another 8% disagreed, and 34 % disagreed strongly.
The last methamphetamine treatment method for which preference by the
respondents was assessed is stimulant treatment. A majority (90%) of the female
respondents were neutral while the remaining 10% strongly disagreed to this approach.
Conversely, the largest proportion of male respondents remained neutral to stimulant
treatment as a method of choice, 24% agreed, 26% disagreed, and 16% disagreed
strongly to stimulant treatment as a preferred method.
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Figure 18. Treatment preference
Perceived Effectiveness of Current Treatment Method
Scientific evidence notwithstanding, patient’s perception of treatment
effectiveness may influence retention. Hence, the researcher sought to determine whether
participants considered their current treatment modality effective or not. Remarkably,
there was a general consensus that current treatment was effective. Specifically, 40% of
female respondents agreed while the other 60% strongly agreed that their treatment was
effective. Conversely, only 8% of male respondents considered their current treatment as
good while the majority (92%) strongly agreed to their current treatment being effective.
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Figure 19. Perceived effectiveness of current treatment method
Current Health
Figure 20 gives an analysis of current health of the respondents. It analyses the
changes in the health of the respondents at the beginning of treatment, after three months,
after six months, and at care programs. At the beginning, 50% of the female respondents
were reserved to make an opinion (neutral), 26% disagreed that their health was good,
while 24% strongly disagreed that their health was good. Conversely, 26% of the male
respondents agreed that their health status as at entry to treatment was good although an
equal proportion disagreed strongly. Similarly, 24% disagreed while an equal proportion
remained neutral to this question.
Majority of the respondents (68%) for both male and female respondents stated
that their health remained neutral after three months. However, 16% of female respondent
agreed that their health after three months in treatment was good while 24% disagreed
that their health improved by the third month of treatment. On the other hand, 24% of
males reported that their health had improved while 8% disagreed with this notion.
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After six months, 50% of the male and female respondents agreed that their health
status had improved, which was a significant rise. In fact, 34% of female respondents and
42% of the male respondents strongly agreed that the 6-month treatment program
improved their health. Notably, only 8% of female respondents and 16% of male
respondents remained neutral to this question. Summative evaluation (after care program)
was a different picture all together because no respondent remained reserved or disagreed
with priori that their heath had improved. In fact, 76% of females and 48% of males
agreed while 24% of females and 52% of males strongly agreed to this observation.

Figure 20. Self-reported current health status as good
Preference to Continue with Treatment
Figure 21 gives a summary of patients’ preference to continue with treatment
program as obtained at the beginning of treatment, after three months, after six months,
and after the care program. The response of the female respondents at the beginning of
treatment indicates that 26% agreed to continue, 16% disagreed, 40% were neutral, 10%
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strongly agreed, and 8% strongly disagreed to continue with the treatment. Conversely,
18% of the male respondents strongly disagreed to continue with treatment at the
beginning of the treatment, 34% disagreed, 40% strongly agreed, while 8% remained
neutral.
Notably, opinion on continuing with treatment after three months of treatment had
greatly changed. For instance, 42% of female respondents strongly agreed to continue
and 34% agreed whereas 24% remained neutral with no one dissenting to continue with
treatment. Paradoxically, majority (52%) male respondents remained neutral with only
28% strongly agreeing to continue and 20% agreeing.
Conspicuously, the phenomenon had greatly changed by the end of six months in
treatment. Specifically, proportion of female respondents remaining neutral had increased
from 24% after three months to 52% after six months. Besides, proportion of neutral male
respondents remained fairly constant at 48%. However, total proportion of females opting
to continue with treatment had changed to 32% agreeing strongly and16% agreeing.
Conversely, 44% of the male respondents strongly agreed to continue while 8% of the
male respondents agreed to continue.
Preference to continue with treatment after the care program also had remarkable
changes. Specifically, 26% of the male respondents remained neutral about continuing,
50% disagreed, 16% strongly disagreed, and only 8% agreed to continue. Conversely,
10% of the female respondents strongly disagreed to continue with treatment, 74%
disagreed, while only 16% agreed to continue with the program.
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Figure 21. Preference to continue with treatment
Satisfaction with Treatment and Support Services Thereto
Figure 22 is a summary of client satisfaction with the treatment program as a
whole and with support services offered during treatment. Notably, 42% of female
respondents reported to have been satisfied with treatment while 58% reported strong
satisfaction with the treatment program vis-à-vis 34% of male respondents who reported
satisfaction, 40% reported strong satisfaction, while 26% remained neutral to this
question.
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Figure 22. Rating of entire program

Conversely, 10% of female respondents reported satisfaction with support
services given as part of treatment program while the remaining 90% reported strong
satisfaction. Paradoxically, majority (66%) male respondents reported satisfaction with
support services while only 34% reported strong satisfaction with support services.

Figure 23. Rating of support services
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Chapter 5: Discussion, Conclusions, and Recommendations
Discussion
With sufficient reference to the existing literature, it is evident that substance
abuse is a major challenge to the society. There are many factors that have come up in the
issue of management and treatment of patients who are addicted to methamphetamine.
This study however noted a gap in the treatment or management of methamphetamine
abusers. It was initially hypothesized that there are significant differences in the way
methamphetamine users respond to the drug and the liberty from addictions. As such, it
prompted an integrated study involving in depth literature review and multiple methods
of data collection such as interviews and questionnaires. It is important to note that the
multiplicity of method strategically counteracted weaknesses of individual methods.
It can be concluded that the study was successful given that it realized a 100%
response rate as anticipated in the estimate sampling of 50 males and 50 females. This
was achieved through extending the targeted number to 158 participants, out of whom
others were found incapable of making informed decisions.
Remarkably, all the three objectives of the study were adequately investigated and the
findings provided the answers to the corresponding research questions. The following is a
discussion of findings along research objectives.
Respondent’s characteristics
Forty percent of respondents in the current study were aged 30-40 years and 24%
were aged 19-30 years. Although not exactly within the given age range, these findings
are within the 20s-30s range reported by Hunt, Kuck, and Truitt (2006), and NSDUH
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(2014), which reported average age at initiation of meth use as 21.6 years. Additionally,
26% of women in the current study and 24% of men were single. Specifically, results for
the women are in tandem with observation by Piper (2008) that single women who use
methamphetamine constitute 15% of all female users. However, Piper’s assertion that the
number of single women who use methamphetamine is approximately four times that of
single men is different from current findings because the proportions were almost equal.
Moreover, 66% of women in the current study and 92% of men had a minimum of
a college education (including ongoing), which reflects a high level of education. These
findings are contrary to claims by NIDA (2000) that women who use methamphetamine
are less likely to have education level beyond high school. However, 60% of women in
the current study reported to have had adverse childhood experiences, which is consistent
with Piper’s (2008) observation that women who use methamphetamine have higher
frequency for physical abuse and psychological trauma.
Reasons for Using Methamphetamine
Identifying reasons for use of methamphetamine was one of the specific
objectives in this study for which data were obtained via the questionnaires. Specifically,
question B-Q8 in Questionnaire B that sought respondents’ condition aided in this task.
Importantly, both the literature review and reconnaissance interview revealed the
following possible reasons for methamphetamine abuse:
•

Reduced fatigue (B-Q8-a).

•

Increased attention (B-Q8-b).

•

Wakefulness (B-Q8-c).
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•

Increased activity (B-Q8-d).

•

Better sex (B-Q8-e).

•

To escape the poignant or emotional distress that is caused by occurrence
of victimization or sexual abuse (B-Q8-f).

•

Partners influence (B-Q8-g).

•

Stress reduction (B-Q8-h).

•

Self-medication (B-Q8-i).

•

Socialization (B-Q8-j).

•

Emotional problems (B-Q8-k).

•

Weight loss (B-Q8-l).

The sole aim of their inclusion was to confirm their validity and severity. Importantly,
Heseltine (2006) already indicated that reasons for taking methamphetamine vary with
gender. Importantly, all these reasons featured significantly in the current study going by
a sum total of participants who ‘agree’ and ‘significantly agreed’ that each factor was a
reason. Notably, acceptance is hereby defined as sum total of ‘agreed’ and ‘significantly
agreed’, denial as sum total of ‘disagree’ and ‘strongly disagree’, while the remainder are
the ones who were neutral.
All female and male respondents accepted that increased attention and increased
activity were reasons behind their use of methamphetamine. Among factors that received
more than 90% acceptance for women were reduced fatigue, increase attention,
wakefulness, increased activity; those with 50-89% were emotional problems, better sex
and stress reduction; and those with less than 50% were weight loss, socialization, partner
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influence, self-medication, and escape from emotional stress from abuse. Conversely,
increased attention, increased activity, and better sex had more than 90% acceptance
among male respondents; reducing fatigue, wakefulness, reduced stress, socialization,
and emotional problems had 50-89%; partner influence, escape from emotional stress
from abuse, had below 50%; and weight loss and self-medication had no male
respondents accepting that they informed their use of methamphetamine.
Key findings are observation that only 42% of women reported that they used
methamphetamine in order to lose weight, which is contrary to assertion by various
researchers that women mostly use methamphetamine to lose weight (Jenner & Lee,
2008; Korte et al., 2014; Piper, 2008). However, the figure is within range reported by
Piper (2008) who argued that 37% of women who had used methamphetamine in a
Californian study had done so to lose weight. The same study had reported 8% of men
who used methamphetamine to have done so to lose weight, which is contrary to findings
in this study where no male respondent accepted to have been informed by weight loss.
According to Abadi et al. (2012), men are likely to use methamphetamine to
socialize and externalize childhood experiences. Remarkably, 48% of men in this study
reported to have used methamphetamine for socialization purposes, which brings about
the role of peer pressure that is known to be a key driver of drug abuse especially among
youths. Interestingly, a significant proportion of study population was youthful.
Additionally, Korte et al. (2014) highlighted that women are more likely to use
methamphetamine as a way of stress reduction, which was indeed conformed in the
current study because 82% of women accepted to this observation. However, the
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proportion of men that also reported to have used methamphetamine to reduce stress
(76%) is almost equal to that of women. Perhaps, other variables such as source and
duration of stress that were not investigated in this study could have contributed to this
observation.
Moreover, the current study reported 96% of men reporting to have used
methamphetamine for purposes of better sex. Brecht et al. (2004) had reported notably
similar findings. Therefore, it suffices to say that men may use methamphetamine just as
they use over-the-counter drugs, oblivious of the fact methamphetamine may cause
addiction. Importantly, it is documented that methamphetamine indeed increases libido in
men though it may also reduce it at high concentrations. This observation should be a
concern to stakeholders in the fight against HIV/AIDs because methamphetamine use
among gay men is rampant and relationship between methamphetamine use and risky
sexual behavior such as unprotected sex is unequivocal (Semple, Grant & Patterson,
2002). In fact, Piper (2008) reported that an estimated 10-20% of gay men use meth.
The current study also indicates that some female respondents used
methamphetamine due to partner influence (16%) and some to escape emotional distress
emanating from abuse including sexual abuse (40%). Notably, Brecht et al. (2014) argued
that these two are common reasons behind women using meth. Similarly, Lex (1995) and
Weissman and O’Boyle (2000) argued that women who use drugs are more likely to have
a partner who use drugs. According to Piper (2008), women who use meth are more
likely to suffer abuse including sexual abuse even 30 days prior to entering treatment.
Perhaps, an observation that a significant proportion of women in this study accepted that
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emotional distress from abuse was a reason could be attributed to Piper’s claim.
Unfortunately, determining rate of abuse such as physical, emotional or sexual, was
beyond the scope of this study.
Finally, a possible explanation as to why all women in the current study reported
wakefulness, increased activity, increased attention as reasons behind their use of meth
could be due to simultaneous pressure from working and academics given that a
significant proportion of respondents was or had pursued higher education. The fact that
male respondents incriminated the same reasons tends to support this hypothesis.
Remarkably, all the reasons listed are thus the causes of the abuse of the drug, though
some reasons are specific to the situations that the individual abusers are faced with as
earlier hypothesized by Anglin et al. (2000).
Effects of Methamphetamine Abuse
It is common knowledge that identifying a remedy to a problem highly depends
on understanding it. This explains why targeting effective treatment for
methamphetamine addicts begun by comprehension of its effect on the victims, who were
distinctly considered by gender for the purpose of establishing gender differences.
Indeed, off-label use, which is also referred to as abuse of methamphetamine has a lot of
adverse effects spanning across physical and behavioral dysfunction.
The effects noted from the interview and literature review and included in the
questionnaire were internalized childhood problems (B-Q11-a), attempted suicide (BQ11-b), skin problems (B-Q11-c), work-related problems (B-Q11-d), stroke and heart
damage (B-Q11-e), psychosis (B-Q11-f), and damage of the nervous system (B-Q11-g).
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Other effects were categorized as psychological functioning that included depression (BQ12-a), decision making capacity (B-Q12-b), risk-taking behavior (B-Q12-c), and
criminal thinking (B-Q12-d).
Findings on effects of methamphetamine use in the current study were as mixed
as the causes. Notably, all male and female respondents reported to have suffered
depression at one point due to methamphetamine use. But for skin disorders in women
that had 90% of women reporting them as common effects, women also reported work
problems, psychosis, criminal thinking, and risk-taking behavior in the range of 50-80%.
Notably, less than 50% of women accepted that internalized childhood problems,
attempted suicide, nervous damage, and impaired decision making were part of effects of
methamphetamine use.
Conversely, all men similarly accepted that depression is a common effect of
methamphetamine use. Additionally, work problems, risk-taking behavior, and skin
problems were also reported by more than 80% of male respondents; criminal behavior,
nervous damage and psychosis were reported by 50-79% of men; and internalized
childhood problems, attempted suicide, and impaired decision making was reported by
less than 50% of male respondents.
Weissman and O’Boyle (2000) reported that the U.S Criminal Justice System has
recorded women as the fastest growing population and attributed this observation to
chemical dependency. Findings from current study appear to resonate to these findings
because 58% of female respondents accepted that methamphetamine abuse had caused
criminal behavior at one point in life. In fact, it is interesting that proportion of women
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reporting criminal thinking secondary to methamphetamine consumption was almost
equal (58% women and 66% men) in the current study. Coincidentally, Brecht et al.
(2004) reported that legal issues are fundamental effects of psychostimulant use. Again,
the current study did not include specific types of criminal activities that respondents had
engaged under methamphetamine influence.
Additionally, risk-taking behavior as a consequence of methamphetamine use was
reported by 60% of women and 92% of men. Notably, Weissman and O’Boyle (2000)
also reported that HIV prevalence among methamphetamine users is higher as compared
to general population partly because of risky behavior such as having unprotected sex
with multiple partners, needle sharing for those using intravenous route of administration,
and prostitution to obtain money for purchasing drugs. The fact that a significant
proportion of men also reported to have used methamphetamine to increase libido is a red
flag.
Notably, more than half the respondents across gender also reported to have
suffered work problems and psychosis. Although the definition of psychosis used herein
does not suite definition by experts such as American Psychological Association,
majority respondents accepted to have suffered key features of psychosis such as
hallucinations, violent behavior and paranoia, which had also been reported by Brecht et
al. (2004) as common among people who abuse methamphetamine.
Additionally, 90% of women and 84% of men in the current study reported to
have had an episode of attempted suicide, which is a key mental disorder. Similarly,
Abadi et al. (2012) and NIDA (2013) concur that women who use meth are at a higher
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risk for suicidal attempts. Importantly, literature indicates that at least a quarter of all
suicidal attempts ultimately lead to suicide, which may contribute to drug-induced deaths
reported by Calcaterra and Binswanger (2013).
Homer et al. (2008) reported that social isolation, depression, and aggression are
common among people who use methamphetamine. The report on depression is a true
reflection of findings in the current study because all respondents across gender accepted
that they had experienced depression attributable to meth use.
Notably, no respondent reported stroke or heart disorders as an effect of
methamphetamine use across gender. The variation in the response could be explained by
cumulative exposure, that is, the longer the duration and perhaps quantity of
methamphetamine consumed the more likely are these rare adverse effects. In fact, Otero
et al. (2006) already pointed towards possibility that rare adverse effects such as stroke or
heart damage may indeed occur with methamphetamine abuse, only that majority drug
users will have received treatment before a sufficient dose is attained.
Progress of Methamphetamine Treatment
Through this objective, the study intended to determine effective methods for
administering treatment to the affected methamphetamine abusers. As such the feasibility
processes involved tracking progress of the participants for a period of six months to
determine the treatment needs of the different gender groups. In summary, there was no
particular treatment that was identified to be suitable for everyone. Addiction was
determined to be a complex ailment albeit one that is manageable with the right kind of
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treatment. Drug Rehabs (2008) argued that the success of a treatment program for drug
abuse requires the victim to be monitored and treated closely for a long period of time.
However, treatment programs were slowed by some identified factors.
The researcher initially focused on barriers and motivators of entry to treatment.
Men overwhelmingly reported stigma as a key barrier to accessing treatment and more
than half the women also concurred. These findings are in tandem with report by Semple,
Grant, and Patterson (2005). A second key barrier identified by both men and women is
parenting and childcare. Several researchers advocating for gender-specific programs
have repeatedly argued that parenting disadvantages women because they feel insecure to
be separated from their children if they were to enter resident rehabilitation programs
(Weissman & O’Boyle, 2000). Besides, issues with adherence in women are also
attributed to parenting role. Paradoxically, more men than women in the current study
reported parenting as a barrier to entering treatment, which is contrary to the above
claims.
Conversely, I focused on a few motivators of entry to treatment including
procreation need, work, available support services, and family and society influence.
Remarkably, all respondents, both men and women, agreed that family and society
influence played a major role in influencing their decision to enter into treatment
program. Notably, Westermeyer and Boedicker (2000) had earlier argued that women are
more likely to enroll for treatment due to family and society norms that disapprove drug
use among women. In fact, Weissman and O’Boyle (2000) also claimed that drug use
among men in several ethnic groups is generally socially tolerated, which is the principle
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of ‘machismo’ that refers to cultural aspect of depicting men as superior to women
insofar as social norms are concerned. The same aspect of family and society pressure on
women appears to have played a role in participants entering treatment program for
procreation purposes. According to Harnandez, Rounsville and Kranzer (2004), society
disapproves pregnant women taking drugs. Although only 16% of women and half of
these reported to have entered treatment for pregnancy related issues, the findings concur
with argument postulated by the above authors.
Moreover, more men than women reported that they joined treatment because of
work-related problems. This finding may be explained by the fact that majority women
who abuse methamphetamine have been observed to be unemployed (NIDA, 2000).
Importantly, a unique variable that could not be tested in the current study but that is
relevant in term of explaining difference in entry to treatment between men and women is
the phenomenon of ‘telescoping’, defined as “gender-specific physiologic consequences
of drug use” (Weissman & O’Boyle, 2000 p. 1). Perhaps, some women could have
experienced severe effects of methamphetamine at the same or even lower serum
concentration of the drug, pushing them to seek for treatment earlier.
Also, I focused on patient’s perceived improvement following treatment
initiation, which was assessed at entry, after 3-months, after 6-months, and after care
program. Notably, men showed greater improvement in majority parameters including
medical problems and family relationships as compared to women. This is despite the
fact that unemployment, childcare responsibilities, living with another drug and/or
alcohol addict, history of sexual or physical abuse, and increased psychiatric symptoms
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were equally noted in men as in women. The study results confirmed that
methamphetamine abusers formed a category of patients with multiple problems in key or
major life. A possible explanation to this finding could be that gender-specific services
that suit women may not have been delivered as advocated for by Weissner and O’Boyle
(2000) and Piper (2008). Nevertheless, both women and men reported satisfaction with
the treatment program and with support services given as part of the long-term treatment
program. Although respondents in this study reported immense success, Jenner and Lee
(2008) noted that rehabilitation centers record higher relapse rate estimated at 88% and
that females tend to have a greater incidence of early termination and/or discharge against
medical advice as compared to men. Unfortunately, relapse and recidivism rates were
beyond the scope of this study due to time limitation.
Additionally, majority respondents in the current study preferred out-patient
treatment (50%), followed by community rehabilitation program (40%), in-patient
rehabilitation (32%), medication (26%), but none preferred stimulant treatment or the
traditional out-patient treatment program. Conversely, majority men (76%) preferred outpatient program, followed by medication (50%), in-patient rehabilitation (42%),
community program (34%), and traditional out-patient and stimulant treatment (24%).
However, an earlier study by Rowan-Szal et al. (2009), had reported patients preferring
community program and traditional outpatient services to other options.
Conclusion
From the analysis of data collected in the three phases of the study and the critical
discussion with respect to the current literature, we can reach at the following
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conclusions. Findings indicate people who use methamphetamine are generally young
and educated. However, men tend to be more educated than women but women are more
likely to be single compared to men. In terms of reasons for using methamphetamine,
increased activity, increased attention, wakefulness, reduced fatigue and reduced stress
cut across gender. However, more men use methamphetamine for enhanced sexual
experience, while more women may be victims of peer pressure from their partners.
Besides, more women may use methamphetamine to lose weight, as self-medication, and
to escape emotional stress related to abuse, both current and in childhood.
Moreover, all highlighted effects of methamphetamine use except stroke and heart
damage were documented, which means they are common. Importantly, depression is a
common psychological effect among both men and women. Additionally, women
reported more skin disorders while men reported risk-taking behavior as a significant
effect of methamphetamine abuse.
Insofar as motivators and barriers to treatment are concerned, the researcher
hereby affirms that stigma is a key barrier for both men and women entering into
treatment program, while parenting may equally affect both men and women contrary to
earlier proposition that more women than men are affected. The most notable motivators
to treatment for both men and women were awareness and family/society support.
In terms of preference to various modalities of treatment, more men preferred outpatient method and medication while women preferred out-patient method and
community program. The later is a replica of CLIFF-TC that has been tested elsewhere
and shown to be effective. Importantly, all respondents reported satisfaction with
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treatment and were indeed observed to have benefitted from treatment despite the short
follow-up period.
Recommendations
This study was limited to a period of six months only. Therefore, it is important
that a longitudinal study that will monitor patients for more than six months be conducted
so that long-term treatment efficacy including relapse rate be determined between female
and males. Additionally, a study that will compare treatment outcomes and costeffectiveness of gender-specific versus mixed-type treatment programs is strongly
recommended.
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Appendix A: Questionnaires

QUESTIONNAIRE A
Respondent’s Suitability Assessment Guide.
This guide is meant to allow the research facilitator establish the suitability of the
respondent making informed consent as it regards to participation in the research. As
such, it helps in achieving the required sample of 50 males and 50 females, which needs
to be done by convenient sampling.
Qualified respondents must
•

be above the age of 18 years or represented by a parent or guardian for the
underage

•

Be able to define themselves

•

Be somehow productive or employed or occupied e.g. being a housewife (NOTE:
The productivity or the role might be influenced negatively by the use of
methamphetamine but the presence of responsibility indicates that the participants
can make informed decision if well informed.

•

Have friends or family for which the relationship must not be violent, abusive or
despised as insane or something to suggest so.

•

Have been at the rehabilitation center for more than 1 week.
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Evaluation table
Gender
Age Group

13-18, 19-30, 30-40, 50-Above

Self-Definition
Responsibility
Social or psychological aspect / functioning
Period of Stay at the clinic

QUESTIONNAIRE B
RESPODENT’s CONDITION ASSESSMENT
Demographics

Q1-Gender
Male

Q2-Age group
Age Group
13-18
19-30
30-40

Female

113
50-Above

Q3-Marital status
Marital Status
Single
Married
Divorced

Minor

Q4-Education level
Educational level
Elementary / Secondary
College / university Degree
Masters and above

,

Health
Q5- Do you have any health complications from your childhood?
YES

NO
1-Strongly

2-

3-

4-

5-

Disagree

Diasgree

Neutral

Agree

Strongly

114
Agree
Severity

………………………………………………………………………………………………
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………………

Q6- Do you have any physical challenges?
YES

NO

………………………………………………………………………………………………
………………………………………………………………………………………………
………………………………………………………………………………………………
……………………………………
Q7- How is your current health as affected by use of methamphetamine?
1-Strongly

2-

Disagree

Diasgree

3-Neutral 4Agree

5Strongly
Agree

Good
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Reasons for using the methamphetamine

Q8- Why did you use the methamphetamine?
1-Strongly 2-

3-

4-

5-

Disagree

Neutral

Agree

Strongly

Diasgree

Agree
•

Reduced fatigue

•

Increased attention

•

Wakefulness

•

increased activity

•

Better Sex

•

to escape the
poignant or
emotional distress
that is caused by the
occurrence of
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victimization or
sexual abuse
•

Married couples
Influenced by their
partners

•

Reduce stress

•

Self-medication

•

Socialize

•

Emotional problems

•

Weight loss

Pattern of drug Abuse
Q9- How did you come to know and abuse the methamphetamine drug?
1-Strongly

2-

3-

Disagree

Diasgree

Neutral

4-Agree 5Strongly
Agree

•

Advice from
Friends

•

Medical office

(anxiety, mood
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disorders, and pain)
•

Incitement from the
first use

•

Incitement from
your partner (for
the married or
engaged or dating)

Q10- What is your consumption rate over the past one month?
1 pellets

2 pellets

3 pellets

4 pellets

5 pellets

Above 5

Daily
average
consumption

Effects of methamphetamine

Q11. Do you have any health complications resulting from the methamphetamine use?
Factors

1-

2-

3-

4-

5-

Strongl

Diasgre

Neutr

Agre

Strongl
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y

e

al

Disagre
e
•

Internalize
d childhood problems

•

Attempted
suicide

•

Skin
problem

•

Work
Related problems

•

stroke, and
heart damage

•

Psychosis

•

Damage of
the nervous system

Q12- How is social and psychological functioning influenced by use of
methamphetamine in terms of the following issues?

e

y Agree
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Factors

1-Strongly

2-Diasgree

3-Neutral

4-Agree

Disagree

5-Strongly
Agree

Depression
decision making
risk taking
criminal thinking

QUESTIONNAIRE C
TREATMENT

Q1- Have you sought any form of treatment before?
YES

NO

Q2- What kind of treatment do you prefer and consider effective for your addiction to
methamphetamine?
1-

2-

3-

4-

5-

Strongly

Diasgree

Neutral

Agree

Strongly

Disagree

Agree
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•

Out-patient

•

In-patient Rehabilitation
traditional outpatient
(OTP) treatments
therapeutic
community program
called clean lifestyle
(CLIFF-TC

•

Medication

•

Stimulant treatment

Q3-How do you gauge the current treatment you are undergoing?
1-Strongly

2-

Disagree

Diasgree

3-Neutral 4Agree

5Strongly
Agree

Good

Q4-What has motivated you into accessing the treatment?
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1-Strongly

2-Diasgree 3-Neutral

4-Agree

Disagree
•

5-Strongly
Agree

family and
society factor

•

The need for
pregnancy for
women into
seeking
treatment?

•

Work

•

Awareness /
support from
the society

………………………………………………………………………………………………
………………………………………………………………….
………………………………………………………………………………………………
………………………………………………………………….
Q5 -What prevented you from getting treatment?
1-Strongly
Disagree

2-Diasgree

3-Neutral

4-Agree

5-Strongly
Agree
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•

Stigma

•

Parenting and
childcare e.g.
the lack of
surrogates to
carry out their
responsibilitie
s

•

Medical
Conditions

•

vocational or
educational
training/
Work

QUESTIONNAIRE D

Continuous Monitoring
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Q1- How is your current health?
Period

1-

2-

3-

Strongly

Diasgree

Neutral

4-Agree 5Strongly

Disagree
•

At the

Agree

Good

Begging
•

After 3

Good

months
•

After 6

Good

months
•

After-

Good

care
Program

Q2- Do you feel like continuing with the program?
Period

1-

2-

3-

4-

5-

Strongly

Diasgree

Neutral

Agree

Strongly

Disagree
•

At the

Continue

Begging

with the
treatment

•

After 3

Continue

Agree
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months

with the
treatment

•

After 6

Continue

months

with the
treatment

•

After-

Continue

care

with the

Program

treatment

3. Do they have the required facilities to handle your conditions including medicine,
support and other kits?
1-Strongly

2-Diasgree

Disagree
The
institution
has
adequate
facilities

QUESTIONNAIRE E
END of PROGRAM QUESTIONNAIRE

3-Neutral

4-Agree

5-Strongly
Agree
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Q1-How do you the rate entire program?
1-Strongly

2-Diasgree

3-Neutral

4-Agree

Disagree

5-Strongly
Agree

Satisfactory

Q2-How do you rate the support given by the experts?
1-Strongly

2-Diasgree

3-Neutral

4-Agree

Disagree

5-Strongly
Agree

Satisfactory

Strengths
………………………………………………………………………………………………
………………………………………………………………….
………………………………………………………………………………………………
………………………………………………………………….
………………………………………………………………………………………………
………………………………………………………………….
Challenges
………………………………………………………………………………………………
………………………………………………………………….
………………………………………………………………………………………………
………………………………………………………………….
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………………………………………………………………………………………………
………………………………………………………………….

Recommendations
………………………………………………………………………………………………
………………………………………………………………….
………………………………………………………………………………………………
………………………………………………………………….
………………………………………………………………………………………………
………………………………………………………………….

